Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vaccines

  Free Subscription

Articles published in
Clin Infect Dis
    August 2022
  1. ZAMBRANO LD, Newhams MM, Olson SM, Halasa NB, et al
    BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years.
    Clin Infect Dis. 2022 Aug 4. pii: 6655523. doi: 10.1093.
    >> Share

  2. ARASHIRO T, Arima Y, Muraoka H, Sato A, et al
    COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection during Delta-dominant and Omicron-dominant periods in Japan: a multi-center prospective case-control study (FASCINATE study).
    Clin Infect Dis. 2022 Aug 3. pii: 6653543. doi: 10.1093.
    >> Share

    July 2022
  3. LEHRNBECHER T, Sack U, Speckmann C, Groll AH, et al
    Longitudinal Immune Response to Three Doses of mRNA Vaccine Against COVID-19 in Pediatric Patients Receiving Chemotherapy for Cancer.
    Clin Infect Dis. 2022 Jul 28. pii: 6651274. doi: 10.1093.
    >> Share

  4. ESPARCIA-PINEDO L, Yarci-Carrion A, Mateo-Jimenez G, Ropero N, et al
    Development of an effective immune response in adults with Down Syndrome after SARS-CoV-2 vaccination.
    Clin Infect Dis. 2022 Jul 23. pii: 6649074. doi: 10.1093.
    >> Share

  5. SAHNI LC, Naioti EA, Olson SM, Campbell AP, et al
    Sustained within-season vaccine effectiveness against influenza-associated hospitalization in children: Evidence from the New Vaccine Surveillance Network, 2015-2016 through 2019-2020.
    Clin Infect Dis. 2022 Jul 22. pii: 6648556. doi: 10.1093.
    >> Share

  6. KLING K, Domingo C, Bogdan C, Duffy S, et al
    Duration of protection after vaccination against yellow fever - systematic review and meta-analysis.
    Clin Infect Dis. 2022 Jul 20. pii: 6646957. doi: 10.1093.
    >> Share

  7. HATFIELD KM, Baggs J, Wolford H, Fang M, et al
    Effectiveness of COVID-19 vaccination against SARS-CoV-2 Infection among Residents of US Nursing Homes, Before and During the Delta variant Predominance, December 2020 - November 2021.
    Clin Infect Dis. 2022 Jul 20. pii: 6646955. doi: 10.1093.
    >> Share

  8. PARAMESWARAN GI, Wattengel BA, Chua HC, Swiderek J, et al
    Increased Stroke Risk Following Herpes Zoster Infection and Protection with Zoster Vaccine.
    Clin Infect Dis. 2022 Jul 7. pii: 6633277. doi: 10.1093.
    >> Share

  9. SANDERS JSF, Lianne Messchendorp A, de Vries RD, Baan CC, et al
    Antibody and T-cell responses 6 months after COVID-19 mRNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant.
    Clin Infect Dis. 2022 Jul 7. pii: 6633280. doi: 10.1093.
    >> Share

  10. TURNER AN, Carter AM, Tzeng YL, Stephens DS, et al
    Infection With the US Neisseria meningitidis Urethritis Clade Does Not Lower Future Risk of Urethral Gonorrhea.
    Clin Infect Dis. 2022;74:2159-2165.
    >> Share

  11. GRANT LR, Slack MPE, Theilacker C, Vojicic J, et al
    Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children from High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination.
    Clin Infect Dis. 2022 Jul 5. pii: 6629370. doi: 10.1093.
    >> Share

    June 2022
  12. GOOD MK, Czarnik M, Harmon KG, Aukerman D, et al
    SARS-CoV-2 Infections and Reinfections among Fully Vaccinated and Unvaccinated University Athletes - 15 States, January - November 2021.
    Clin Infect Dis. 2022 Jun 30. pii: 6623463. doi: 10.1093.
    >> Share

  13. GLATMAN-FREEDMAN A, Feldman SF, Hershkovitz Y, Kaufman Z, et al
    Vaccine coverage associated with ending a SARS-CoV-2 wave: a retrospective longitudinal analysis.
    Clin Infect Dis. 2022 Jun 28. pii: 6619125. doi: 10.1093.
    >> Share

  14. MOLINE HL, Keaton A, Rice W, Varghese J, et al
    Effectiveness of COVID-19 mRNA vaccines against infection during an outbreak of SARS-CoV-2 Beta (B.1.351) variant in a skilled nursing facility - Virginia, March-April 2021.
    Clin Infect Dis. 2022 Jun 27. pii: 6618595. doi: 10.1093.
    >> Share

  15. OH DY, Holzer M, Paraskevopoulou S, Trofimova M, et al
    Advancing Precision Vaccinology by Molecular and Genomic Surveillance of SARS-CoV-2 in Germany, 2021.
    Clin Infect Dis. 2022 Jun 25. pii: 6617635. doi: 10.1093.
    >> Share

  16. KUTTY PK, Stuckey MJ, Koumans EH
    Vaccines, Variants, and Vigilance: Strengthening the COVID-19 Public Health Response through Partnerships and Collaborations.
    Clin Infect Dis. 2022 Jun 24. pii: 6617337. doi: 10.1093.
    >> Share

  17. CHOI D, Nielsen J, Waller LA, Patel SA, et al
    The US COVID-19 surveillance environment: An ecological analysis of the relationship of testing adequacy in the context of vaccination.
    Clin Infect Dis. 2022 Jun 24. pii: 6617111. doi: 10.1093.
    >> Share

  18. PLOTKIN SA
    Why We Need Precision Vaccinology.
    Clin Infect Dis. 2022 Jun 23. pii: 6615391. doi: 10.1093.
    >> Share

  19. MORROCCHI E, Pighi C, Pascucci GR, Cotugno N, et al
    Perinatally HIV-infected adolescents and young adults demonstrate distinct BNT162b2 mRNA COVID-19 vaccine immunogenicity.
    Clin Infect Dis. 2022 Jun 23. pii: 6615389. doi: 10.1093.
    >> Share

  20. OHLSEN EC, Yankey D, Pezzi C, Kriss JL, et al
    COVID-19 vaccination coverage, intentions, attitudes and barriers by race/ethnicity, language of interview, and nativity, National Immunization Survey Adult COVID Module, April 22, 2021-January 29, 2022.
    Clin Infect Dis. 2022 Jun 23. pii: 6614630. doi: 10.1093.
    >> Share

  21. BROSH-NISSIMOV T, Hussein K, Wiener-Well Y, Orenbuch-Harroch E, et al
    Hospitalized patients with severe COVID-19 during the Omicron wave in Israel - benefits of a fourth vaccine dose.
    Clin Infect Dis. 2022 Jun 20. pii: 6611845. doi: 10.1093.
    >> Share

  22. ROSKOSKY M, Moni G, Kawakami V, Lambert J, et al
    SARS-CoV-2 Transmission Associated with an Indoor Music Event That Required Proof of Full Vaccination Against COVID-19 Prior to Entry-Seattle, July 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611550. doi: 10.1093.
    >> Share

  23. VU DM, Vu DTB, Do TTT, Olmsted AE, et al
    Presence of SARS-CoV-2 Antibodies among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine.
    Clin Infect Dis. 2022 Jun 20. pii: 6611567. doi: 10.1093.
    >> Share

  24. RICHARDSON VL, Franco MAC, Marquez AB, Valdez LM, et al
    Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers - Mexico, March-December 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611492. doi: 10.1093.
    >> Share

  25. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
    Kinetics of maternally-derived anti- SARS-CoV-2 antibodies in infants in relation to the timing of antenatal vaccination.
    Clin Infect Dis. 2022 Jun 19. pii: 6611486. doi: 10.1093.
    >> Share

  26. MONGE S, Rojas-Benedicto A, Olmedo C, Martin-Merino E, et al
    Effectiveness of a second dose of an mRNA vaccine against SARS-CoV-2 Omicron infection in individuals previously infected by other variants.
    Clin Infect Dis. 2022 Jun 10. pii: 6605647. doi: 10.1093.
    >> Share

  27. LIM SY, Park S, Kim JY, Kim S, et al
    Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural SARS-CoV-2 Infection (With/Without subsequent COVID-19 Vaccination) Versus 2-dose COVID-19 Vaccination.
    Clin Infect Dis. 2022 Jun 10. pii: 6605068. doi: 10.1093.
    >> Share

  28. RUHLAND A, Fell A, Holzbauer SM, D'Heilly P, et al
    Exposure Outcomes in Fully Vaccinated Healthcare Personnel with Known SARS-CoV-2 Exposure-Minnesota, January-August 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605065. doi: 10.1093.
    >> Share

  29. BUSCH MP, Stramer SL, Stone M, Yu EA, et al
    Population-weighted seroprevalence from SARS-CoV-2 infection, vaccination, and hybrid immunity among U.S. blood donations from January-December 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605072. doi: 10.1093.
    >> Share

  30. LI ZN, Liu F, Jefferson S, Horner L, et al
    Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza.
    Clin Infect Dis. 2022 Jun 10. pii: 6605070. doi: 10.1093.
    >> Share

  31. TOP KA, Chen RT, Levy O, Ozonoff A, et al
    Advancing the Science of Vaccine Safety during the COVID-19 Pandemic and Beyond: Launching an International Network of Special Immunization Services.
    Clin Infect Dis. 2022 Jun 9. pii: 6605049. doi: 10.1093.
    >> Share

  32. WAN EYF, Chui CSL, Ng VWS, Wang Y, et al
    mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell's palsy: a nested case control and self-controlled case series study.
    Clin Infect Dis. 2022 Jun 8. pii: 6604461. doi: 10.1093.
    >> Share

  33. BART SM, Curtiss CC, Earnest R, Lobe-Costonis R, et al
    SARS-CoV-2 Outbreak at a College with High COVID-19 Vaccination Coverage-Connecticut, August-September 2021.
    Clin Infect Dis. 2022 Jun 8. pii: 6604453. doi: 10.1093.
    >> Share

  34. LEWIS NM, Self WH, Gaglani M, Ginde AA, et al
    Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
    Clin Infect Dis. 2022 Jun 8. pii: 6604454. doi: 10.1093.
    >> Share

  35. LEUNG NHL, Cheng SMS, Martin-Sanchez M, Au NYM, et al
    Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine.
    Clin Infect Dis. 2022 Jun 8. pii: 6604400. doi: 10.1093.
    >> Share

  36. RICHTERMAN A, Behrman A, Brennan PJ, O'Donnell JA, et al
    Durability of SARS-CoV-2 mRNA Booster Vaccine Protection Against Omicron Among Health Care Workers with a Vaccine Mandate.
    Clin Infect Dis. 2022 Jun 6. pii: 6603294. doi: 10.1093.
    >> Share

  37. BRUXVOORT KJ, Lewnard JA, Chen LH, Tseng HF, et al
    Prevention of Neisseria gonorrhoeae with meningococcal B vaccine: a matched cohort study in Southern California.
    Clin Infect Dis. 2022 Jun 1. pii: 6596517. doi: 10.1093.
    >> Share

  38. HAVERS FP, Skoff TH, Rench MA, Epperson M, et al
    Maternal Tdap Vaccination during Pregnancy: Impact on Infant Anti-pertussis Antibody Concentrations by Maternal Pertussis Priming Series.
    Clin Infect Dis. 2022 Jun 1. pii: 6596516. doi: 10.1093.
    >> Share

    May 2022
  39. ISHOLA D
    Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children.
    Clin Infect Dis. 2022 May 30. pii: 6595436. doi: 10.1093.
    >> Share

  40. ANGLEMYER A, McNeill A, DuBray K, Sonder GJB, et al
    Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand.
    Clin Infect Dis. 2022;74:1859-1861.
    >> Share

  41. MEIRING S, Tempia S, Dominic EM, de Gouveia L, et al
    Excess Invasive Meningococcal Disease Associated With Seasonal Influenza, South Africa, 2003-2018.
    Clin Infect Dis. 2022;74:1729-1735.
    >> Share

  42. MARRA AR, Miraglia JL, Malheiros DT, Guozhang Y, et al
    Effectiveness of heterologous COVID-19 vaccine booster dosing in Brazilian healthcare workers, 2021.
    Clin Infect Dis. 2022 May 27. pii: 6594056. doi: 10.1093.
    >> Share

  43. PATEL SS, Rauscher M, Kudela M, Pang H, et al
    Clinical Safety Experience of TAK-003 for Dengue Fever: a new Tetravalent Live Attenuated Vaccine Candidate.
    Clin Infect Dis. 2022 May 26. pii: 6593313. doi: 10.1093.
    >> Share

  44. ZHAO M, Slotkin R, Sheth AH, Pischel L, et al
    Serum Neutralizing Antibody Titers 12 months after COVID-19 mRNA Vaccination: Correlation to Clinical Variables in an Adult, US-Population.
    Clin Infect Dis. 2022 May 26. pii: 6593314. doi: 10.1093.
    >> Share

  45. PETROS BA, Turcinovic J, Welch NL, White LF, et al
    Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations.
    Clin Infect Dis. 2022 May 25. pii: 6591846. doi: 10.1093.
    >> Share

  46. GRIMA AA, Murison KR, Simmons AE, Tuite AR, et al
    Relative Virulence of SARS-CoV-2 Among Vaccinated and Unvaccinated Individuals Hospitalized with SARS-CoV-2.
    Clin Infect Dis. 2022 May 25. pii: 6591845. doi: 10.1093.
    >> Share

  47. EPSI NJ, Richard SA, Lindholm DA, Mende K, et al
    Understanding 'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines.
    Clin Infect Dis. 2022 May 24. pii: 6591282. doi: 10.1093.
    >> Share

  48. CORRADINI P, Agrati C, Apolone G, Mantovani A, et al
    Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study.
    Clin Infect Dis. 2022 May 24. pii: 6590993. doi: 10.1093.
    >> Share

  49. LOFGREN E, Naumova EN, Gorski J, Naumov Y, et al
    How drivers of seasonality in respiratory infections may impact vaccine strategy: a case study in how COVID-19 may help us solve one of influenza's biggest challenges.
    Clin Infect Dis. 2022 May 24. pii: 6590989. doi: 10.1093.
    >> Share

  50. EYAL N, Gheaus A, Gosseries A, Magalhaes M, et al
    COVID vaccine prioritization in low- and middle-income countries may justifiably depart from high-income countries' age priorities.
    Clin Infect Dis. 2022 May 24. pii: 6590988. doi: 10.1093.
    >> Share

  51. LAGOUSI T, Papadatou I, Strempas P, Chatzikalil E, et al
    PAVING THE WAY TOWARDS PRECISION VACCINOLOGY: THE PARADIGM OF MYOCARDITIS AFTER COVID-19 VACCINATION.
    Clin Infect Dis. 2022 May 24. pii: 6590985. doi: 10.1093.
    >> Share

  52. SHAPIRO JR, Sitaras I, Park HS, Aytenfisu TY, et al
    Association of frailty, age, and biological sex with SARS-CoV-2 mRNA vaccine-induced immunity in older adults.
    Clin Infect Dis. 2022 May 24. pii: 6590987. doi: 10.1093.
    >> Share

  53. ROTTENSTREICH A, Vorontsov O, Alfi O, Zarbiv G, et al
    Maternal and Neonatal SARS-CoV-2 Omicron Variant Neutralization after Antenatal mRNA Vaccination.
    Clin Infect Dis. 2022 May 24. pii: 6590984. doi: 10.1093.
    >> Share

  54. LEVIN-RECTOR A, Firestein L, McGibbon E, Sell J, et al
    Reduced Odds of SARS-CoV-2 Reinfection after Vaccination among New York City Adults, July-November 2021.
    Clin Infect Dis. 2022 May 20. pii: 6589783. doi: 10.1093.
    >> Share

  55. TENFORDE MW, Self WH, Zhu Y, Naioti EA, et al
    Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States.
    Clin Infect Dis. 2022 May 17. pii: 6587132. doi: 10.1093.
    >> Share

  56. MARTINUZZI E, Benzaquen J, Guerin O, Leroy S, et al
    A Single Dose of BNT162b2 mRNA Vaccine Induces Airway Immunity in SARS-CoV-2 Naive and recovered COVID-19 subjects.
    Clin Infect Dis. 2022 May 17. pii: 6586846. doi: 10.1093.
    >> Share

  57. WEITZMAN ER, Kossowsky J, Blakemore LM, Cox R, et al
    Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making.
    Clin Infect Dis. 2022 May 17. pii: 6586840. doi: 10.1093.
    >> Share

  58. WEITZMAN ER, Sherman AC, Levy O
    Pediatric SARS-CoV-2 Vaccines: Perceptions and Attitudes from the FDA Public Commentary.
    Clin Infect Dis. 2022 May 17. pii: 6586838. doi: 10.1093.
    >> Share

  59. BARI A, Heymann M, Cohen RJ, Zhao R, et al
    Exploring Coronavirus Disease 2019 Vaccine Hesitancy on Twitter Using Sentiment Analysis and Natural Language Processing Algorithms.
    Clin Infect Dis. 2022;74.
    >> Share

  60. POH XY, Tan CW, Lee IR, Chavatte JM, et al
    Antibody response of heterologous vs homologous mRNA vaccine boosters against the SARS-CoV-2 Omicron variant: interim results from the PRIBIVAC study, A Randomized Clinical Trial.
    Clin Infect Dis. 2022 May 11. pii: 6583615. doi: 10.1093.
    >> Share

  61. CONTI MG, Terreri S, Terrin G, Natale F, et al
    SARS-CoV-2 infection versus vaccination in pregnancy: Implications for maternal and infant immunity.
    Clin Infect Dis. 2022 May 10. pii: 6583148. doi: 10.1093.
    >> Share

  62. SPARKE M, Levy O
    Competing responses to global inequalities in access to COVID vaccines: Vaccine Diplomacy and Vaccine Charity Versus Vaccine Liberty.
    Clin Infect Dis. 2022 May 10. pii: 6583150. doi: 10.1093.
    >> Share

  63. ZURCHER K, Abela IA, Stange M, Dupont C, et al
    Alpha variant coronavirus outbreak in a nursing home despite high vaccination coverage: molecular, epidemiological and immunological studies.
    Clin Infect Dis. 2022 May 6. pii: 6582009. doi: 10.1093/cid/ciab1005.
    >> Share

  64. DOWLING DJ, Levy O
    A Precision Adjuvant Approach to Enhance SARS-CoV-2 Vaccines Optimized for Immunologically Distinct Vulnerable Populations.
    Clin Infect Dis. 2022 May 4. pii: 6580093. doi: 10.1093.
    >> Share

  65. BUTT AA, Talisa VB, Shaikh OS, Omer SB, et al
    Relative Vaccine Effectiveness of a SARS-CoV-2 mRNA Vaccine Booster Dose Against the Omicron Variant.
    Clin Infect Dis. 2022 May 3. pii: 6577096. doi: 10.1093.
    >> Share

  66. BEN-SHIMOL S, Regev-Yochay G, Givon-Lavi N, van der Beek BA, et al
    Dynamics of Invasive Pneumococcal Disease in Israel in Children and Adults in the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Era: A Nationwide Prospective Surveillance.
    Clin Infect Dis. 2022;74:1639-1649.
    >> Share

    April 2022
  67. CHOW EPF, Fairley CK, Zou H, Wigan R, et al
    Correction to: Human Papillomavirus Antibody Levels Following Vaccination or Natural Infection Among Young Men Who Have Sex With Men.
    Clin Infect Dis. 2022 Apr 27. pii: 6574995. doi: 10.1093.
    >> Share

  68. BUSKERMOLEN M, Molthof I, Voeten HA, van Twillert J, et al
    Vaccination did not prevent severe COVID in an outbreak among older residents of a nursing home, B.1.617.2 variant, July 2021.
    Clin Infect Dis. 2022 Apr 27. pii: 6574733. doi: 10.1093.
    >> Share

  69. SHRESTHA NK, Shrestha P, Burke PC, Nowacki AS, et al
    Coronavirus Disease 2019 (COVID-19) Vaccine Boosting in Previously Infected or Vaccinated Individuals.
    Clin Infect Dis. 2022 Apr 27. pii: 6574819. doi: 10.1093.
    >> Share

  70. SHARMA A, Oda G, Holodniy M
    Effectiveness of mRNA-based vaccines during the emergence of SARS-CoV-2 Omicron variant.
    Clin Infect Dis. 2022 Apr 27. pii: 6574744. doi: 10.1093.
    >> Share

  71. SOLERA JT, Arbol BG, Alshahrani A, Bahinskaya I, et al
    Impact of Vaccination and Early Monoclonal Antibody Therapy on COVID-19 Outcomes in Organ Transplant Recipients During the Omicron Wave.
    Clin Infect Dis. 2022 Apr 21. pii: 6571785. doi: 10.1093.
    >> Share

  72. ZAHRA FT, Grubbs G, Dummer K, Tremoulet AH, et al
    Neutralization of SARS-CoV-2 Omicron and other variants in serum from children with vaccination-induced myocarditis.
    Clin Infect Dis. 2022 Apr 21. pii: 6571576. doi: 10.1093.
    >> Share

  73. KIM J, Choe YJ, Jang EJ, Lim DS, et al
    Effectiveness of Booster mRNA Vaccines against SARS-CoV-2 Infection in Elderly Population, South Korea, October 2021 - January 2022.
    Clin Infect Dis. 2022 Apr 19. pii: 6570782. doi: 10.1093.
    >> Share

  74. NANISHI E, Angelidou A, Rotman C, Dowling DJ, et al
    Precision Vaccine Adjuvants for Older Adults: A Scoping Review.
    Clin Infect Dis. 2022 Apr 19. pii: 6570880. doi: 10.1093.
    >> Share

  75. LEVY O, Angelidou A, Idoko O, Lewis NP, et al
    Precision Vaccines: Lessons Learned from the Coronavirus Pandemic.
    Clin Infect Dis. 2022 Apr 19. pii: 6570826. doi: 10.1093.
    >> Share

  76. WOLDEMESKEL BA, Garliss CC, Aytenfisu TY, Johnston TS, et al
    Discordant antibody and T cell responses to the SARS-CoV-2 Omicron variant in COVID-19 mRNA vaccine recipient.
    Clin Infect Dis. 2022 Apr 19. pii: 6570698. doi: 10.1093.
    >> Share

  77. SKOWRONSKI DM, Febriani Y, Ouakki M, Setayeshgar S, et al
    Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada.
    Clin Infect Dis. 2022 Apr 19. pii: 6570607. doi: 10.1093.
    >> Share

  78. MAEDA H, Saito N, Igarashi A, Ishida M, et al
    Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the Delta variant epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS).
    Clin Infect Dis. 2022 Apr 19. pii: 6570603. doi: 10.1093.
    >> Share

  79. MOORE HC, Cannon JW, Kaslow DC, Lamagni T, et al
    A systematic framework for prioritising burden of disease data required for vaccine development and implementation: the case for group A streptococcal diseases.
    Clin Infect Dis. 2022 Apr 19. pii: 6570502. doi: 10.1093.
    >> Share

  80. SHERMAN AC, Rouphael N, Baden LR
    COVID-19 Vaccine Trials (and Tribulations): How to improve the process of clinical trials in a pandemic.
    Clin Infect Dis. 2022 Apr 18. pii: 6569988. doi: 10.1093.
    >> Share

  81. DALE AP, Almendares O, Howard B, Burnett E, et al
    Investigation of A SARS-CoV-2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis - Maricopa County, Arizona, June-July 2021.
    Clin Infect Dis. 2022 Apr 12. pii: 6567536. doi: 10.1093.
    >> Share

  82. PREMIKHA M, Chiew CJ, Wei WE, Leo YS, et al
    Comparative Effectiveness of mRNA and Inactivated Whole Virus Vaccines against COVID-19 Infection and Severe Disease in Singapore.
    Clin Infect Dis. 2022 Apr 12. pii: 6567428. doi: 10.1093.
    >> Share

  83. TADESSE BT, Khanam F, Ahmed F, Im J, et al
    Prevention of typhoid by Vi conjugate vaccine and achievable improvements in household WASH: Evidence from a cluster-randomized trial in Dhaka, Bangladesh.
    Clin Infect Dis. 2022 Apr 12. pii: 6567455. doi: 10.1093.
    >> Share

  84. RZYMSKI P, Falfushynska H, Fal A
    Vaccination of Ukrainian Refugees: Need for Urgent Action.
    Clin Infect Dis. 2022 Apr 11. pii: 6569707. doi: 10.1093.
    >> Share

  85. GAZIT S, Shlezinger R, Perez G, Lotan R, et al
    SARS-CoV-2 Naturally Acquired Immunity vs. Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: a Retrospective Cohort Study.
    Clin Infect Dis. 2022 Apr 5. pii: 6563799. doi: 10.1093.
    >> Share

  86. ANTINORI A, Cicalini S, Meschi S, Bordoni V, et al
    Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count.
    Clin Infect Dis. 2022 Apr 2. pii: 6562777. doi: 10.1093.
    >> Share

    March 2022
  87. DOLL MK, Pettigrew SM, Ma J, Verma A, et al
    Effects of Confounding Bias in COVID-19 and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors.
    Clin Infect Dis. 2022 Mar 24. pii: 6553950. doi: 10.1093.
    >> Share

  88. NG OT, Koh V, Chiew CJ, Marimuthu K, et al
    Impact of SARS-CoV-2 Vaccination and Paediatric Age on Delta Variant Household Transmission.
    Clin Infect Dis. 2022 Mar 22. pii: 6551710. doi: 10.1093.
    >> Share

  89. GIMENEZ E, Albert E, Zulaica J, Torres I, et al
    SARS-CoV-2 adaptive immunity in nursing home residents following a third dose of the Comirnaty(R) COVID-19 vaccine.
    Clin Infect Dis. 2022 Mar 21. pii: 6551700. doi: 10.1093.
    >> Share

  90. GALLAGHER KME, Leick MB, Larson RC, Berger TR, et al
    Differential T cell immunity to SARS-CoV-2 in mRNA-1273 and BNT162b2 vaccinated individuals.
    Clin Infect Dis. 2022 Mar 12. pii: 6547848. doi: 10.1093.
    >> Share

  91. RIFE MAGALIS B, Rich S, Tagliamonte MS, Mavian C, et al
    SARS-CoV-2 Delta vaccine breakthrough transmissibility in Alachua County, Florida.
    Clin Infect Dis. 2022 Mar 10. pii: 6546683. doi: 10.1093.
    >> Share

  92. BALCELLS ME, Le Corre N, Duran J, Ceballos ME, et al
    Reduced immune response to inactivated SARS-CoV-2 vaccine in a cohort of immunocompromised patients in Chile.
    Clin Infect Dis. 2022 Mar 7. pii: 6543937. doi: 10.1093.
    >> Share

  93. MOORLAG SJCFM, Taks E, Ten Doesschate T, van der Vaart TW, et al
    Efficacy of Bacillus Calmette-Guerin vaccination against respiratory tract infections in the elderly during the Covid-19 pandemic.
    Clin Infect Dis. 2022 Mar 5. pii: 6543010. doi: 10.1093.
    >> Share

  94. POLLOCK BD, Storlie CB, Tande AJ, Sampathkumar P, et al
    Real-world incidence of breakthrough COVID-19 hospitalization after vaccination versus natural infection in a large, local, empaneled primary care population using time-to-event analysis.
    Clin Infect Dis. 2022 Mar 5. pii: 6542971. doi: 10.1093.
    >> Share

  95. BUTT AA, Talisa VB, Yan P, Shaikh OS, et al
    Vaccine Effectiveness of Three vs. Two Doses of SARS-CoV-2 mRNA Vaccines in a High Risk National Population.
    Clin Infect Dis. 2022 Mar 4. pii: 6542712. doi: 10.1093.
    >> Share

  96. SPEICH B, Chammartin F, Abela IA, Amico P, et al
    Antibody response in immunocompromised patients after the administration of SARS-CoV-2 vaccine BNT162b2 or mRNA-1273: A randomised controlled trial.
    Clin Infect Dis. 2022 Mar 2. pii: 6540899. doi: 10.1093.
    >> Share

  97. GANDHI M
    Immunity Against the Omicron Variant from Vaccination, Recovery or Both.
    Clin Infect Dis. 2022 Mar 2. pii: 6540839. doi: 10.1093.
    >> Share

    February 2022
  98. BERENDSEN MLT, Silva I, Bale C, Nielsen S, et al
    The effect of a second dose of measles vaccine at 18 months of age on non-accidental deaths and hospital admissions in Guinea-Bissau: interim analysis of a randomized controlled trial.
    Clin Infect Dis. 2022 Feb 26. pii: 6537530. doi: 10.1093.
    >> Share

  99. HAIDAR G, Agha M, Bilderback A, Lukanski A, et al
    Prospective evaluation of COVID-19 vaccine responses across a broad spectrum of immunocompromising conditions: the COVICS study.
    Clin Infect Dis. 2022 Feb 18. pii: 6530582. doi: 10.1093.
    >> Share

  100. LI C, Ye Z, Zhang AJ, Chan JF, et al
    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections by intranasal or testicular inoculation induces testicular damage preventable by vaccination in golden Syrian hamsters.
    Clin Infect Dis. 2022 Feb 18. pii: 6530400. doi: 10.1093.
    >> Share

  101. BECERRA-CULQUI TA, Getahun D, Chiu V, Sy LS, et al
    Prenatal influenza vaccination or influenza infection and autism spectrum disorder in offspring.
    Clin Infect Dis. 2022 Feb 17. pii: 6528744. doi: 10.1093.
    >> Share

  102. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
    The effect of gestational age at BNT162b2 mRNA vaccination on maternal and neonatal SARS-CoV-2 antibody levels.
    Clin Infect Dis. 2022 Feb 16. pii: 6529520. doi: 10.1093.
    >> Share

  103. GAO DX, Fisher LD, Miller DR, Geller AC, et al
    Inequities in COVID-19 vaccination rates among adolescents in Massachusetts: a cross-sectional study.
    Clin Infect Dis. 2022 Feb 13. pii: 6527834. doi: 10.1093.
    >> Share

  104. HEININGER U
    Diphtheria, Tetanus, and Pertussis: Unequal Vaccine Siblings With Distinct Characteristics.
    Clin Infect Dis. 2022;74:562-563.
    >> Share

  105. CONTOPOULOS-IOANNIDIS DG, Altamirano J, Maldonado Y
    Infectious Diseases-Related Hospitalizations During Oral Polio Vaccine(OPV) and non-OPV immunization periods: An Empirical Evaluation of all Hospital Discharges in California(1985-2010).
    Clin Infect Dis. 2022 Feb 9. pii: 6525447. doi: 10.1093.
    >> Share

  106. BUTT AA, Talisa VB, Yan P, Shaikh OS, et al
    Real-world Effectiveness of the SARS-CoV-2 mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis.
    Clin Infect Dis. 2022 Feb 9. pii: 6525466. doi: 10.1093.
    >> Share

  107. RISK M, Shen C, Hayek SS, Holevinski L, et al
    Comparative Effectiveness of COVID-19 Vaccines against the Delta Variant.
    Clin Infect Dis. 2022 Feb 7. pii: 6523819. doi: 10.1093.
    >> Share

  108. HELMSDAL G, Hansen OK, Moller LF, Christiansen DH, et al
    Omicron outbreak at a private gathering in the Faroe Islands, infecting 21 of 33 triple-vaccinated healthcare workers.
    Clin Infect Dis. 2022 Feb 3. pii: 6520882. doi: 10.1093.
    >> Share

  109. ONG SWX, Sutjipto S, Lee PH, Dugan C, et al
    Validation of ISARIC 4C mortality and deterioration scores in a mixed vaccination status cohort of hospitalized COVID-19 patients in Singapore.
    Clin Infect Dis. 2022 Feb 3. pii: 6520952. doi: 10.1093.
    >> Share

  110. PISCHEL L, Patel KM, Goshua G, Omer SB, et al
    Adenovirus-based vaccines and thrombosis in pregnancy: A systematic review and meta-analysis.
    Clin Infect Dis. 2022 Feb 2. pii: 6520532. doi: 10.1093.
    >> Share

  111. NOUSHAD M, Al-Awar MS, Al-Saqqaf IS, Nassani MZ, et al
    Lack of access to COVID-19 vaccines could be a greater threat than vaccine hesitancy in low-income and conflict nations: the case of Yemen.
    Clin Infect Dis. 2022 Feb 2. pii: 6520556. doi: 10.1093.
    >> Share

    January 2022
  112. HOLMDAHL I, Kahn R, Slifka KJ, Dooling K, et al
    Modeling the impact of vaccination strategies for nursing homes in the context of increased SARS-CoV-2 community transmission and variants.
    Clin Infect Dis. 2022 Jan 29. pii: 6517371. doi: 10.1093.
    >> Share

  113. WATKINS LKF, Mitruka K, Dorough L, Bressler SS, et al
    Characteristics of Reported Deaths Among Fully Vaccinated Persons with COVID-19 -United States, January-April 2021.
    Clin Infect Dis. 2022 Jan 29. pii: 6517385. doi: 10.1093.
    >> Share

  114. MAERTENS K, Orije MRP, Herzog SA, Mahieu LM, et al
    Pertussis Immunization During Pregnancy: Assessment of the Role of Maternal Antibodies on Immune Responses in Term and Preterm-Born Infants.
    Clin Infect Dis. 2022;74:189-198.
    >> Share

  115. SPAULDING AC, Zawitz C
    Vaccination in Prisons and Jails: Corrections Needed in Future Plans.
    Clin Infect Dis. 2022 Jan 27. pii: 6515673. doi: 10.1093/cid/ciab1031.
    >> Share

  116. CHIN ET, Leidner D, Zhang Y, Long E, et al
    Effectiveness of COVID-19 vaccines among incarcerated people in California state prisons: retrospective cohort study.
    Clin Infect Dis. 2022 Jan 27. pii: 6515675. doi: 10.1093/cid/ciab1032.
    >> Share

  117. LAWRENZ J, Xie Q, Zech F, Weil T, et al
    SARS-CoV-2 Vaccination boosts Neutralizing Activity against Seasonal Human Coronaviruses.
    Clin Infect Dis. 2022 Jan 25. pii: 6515378. doi: 10.1093.
    >> Share

  118. LIU J, Laurie MT, Rubio L, Vazquez SE, et al
    SARS-CoV-2 transmission dynamics and immune responses in a household of vaccinated persons.
    Clin Infect Dis. 2022 Jan 17. pii: 6509064. doi: 10.1093.
    >> Share

  119. MUSSI-PINHATA MM, Ward S, Laimon L, Pelton SI, et al
    Effect of Maternal Vaccination of PCV-10, PPV-23 or Placebo on the Immunogenicity of PCV-10 in HIV-exposed Uninfected Infants: A Randomized Clinical Trial.
    Clin Infect Dis. 2022 Jan 17. pii: 6509061. doi: 10.1093.
    >> Share

  120. SHRESTHA NK, Burke PC, Nowacki AS, Terpeluk P, et al
    Necessity of COVID-19 Vaccination in Persons Who Have Already Had COVID-19.
    Clin Infect Dis. 2022 Jan 13. pii: 6507165. doi: 10.1093.
    >> Share

  121. OLSON SM, Newhams MM, Halasa NB, Feldstein LR, et al
    Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children.
    Clin Infect Dis. 2022 Jan 13. pii: 6506316. doi: 10.1093.
    >> Share

  122. HEFTDAL LD, Schultz M, Lange T, Knudsen AD, et al
    Incidence of positive SARS-CoV-2 PCR after COVID-19 vaccination with up to eight months of follow-up: Real life data from the Capital Region of Denmark.
    Clin Infect Dis. 2022 Jan 7. pii: 6500168. doi: 10.1093.
    >> Share

  123. LI X, Chan JM, Lam B, Lung DC, et al
    COVID-19 mRNA vaccines delay the onset of breakthrough infections with less radiographic abnormalities.
    Clin Infect Dis. 2022 Jan 4. pii: 6497432. doi: 10.1093/cid/ciab1062.
    >> Share

    December 2021
  124. CHOW EPF, Fairley CK, Zou H, Wigan R, et al
    Human papillomavirus antibody levels following vaccination or natural infection among young men who have sex with men.
    Clin Infect Dis. 2021 Dec 31. pii: 6491220. doi: 10.1093/cid/ciab1052.
    >> Share

  125. LEWNARD JA, Bruxvoort KJ, Fischer H, Hong VX, et al
    Effectiveness of 13-valent pneumococcal conjugate vaccine against medically-attended lower respiratory tract infection and pneumonia among older adults.
    Clin Infect Dis. 2021 Dec 30. pii: 6490150. doi: 10.1093/cid/ciab1051.
    >> Share

  126. YAMAMOTO S, Maeda K, Matsuda K, Tanaka A, et al
    COVID-19 breakthrough infection and post-vaccination neutralizing antibody among healthcare workers in a referral hospital in Tokyo: a case-control matching study.
    Clin Infect Dis. 2021 Dec 24. pii: 6482345. doi: 10.1093/cid/ciab1048.
    >> Share

  127. ESSINK B, Sabharwal C, Cannon K, Frenck R, et al
    Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults 18 Years and Older.
    Clin Infect Dis. 2021 Dec 23. pii: 6481672. doi: 10.1093.
    >> Share

  128. DAGAN R, Van Der Beek BA, Ben-Shimol S, Pilishvili T, et al
    Corrigendum to: Effectiveness of the 7- and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-Serotype Otitis Media.
    Clin Infect Dis. 2021 Dec 21. pii: 6472232. doi: 10.1093.
    >> Share

  129. SACHDEV DD, Chew Ng R, Sankaran M, Ernst A, et al
    Contact tracing outcomes among household contacts of fully vaccinated COVID-19 patients - San Francisco, California, January 29-July 2, 2021.
    Clin Infect Dis. 2021 Dec 20. pii: 6470866. doi: 10.1093/cid/ciab1042.
    >> Share

  130. TYNER HL, Burgess JL, Grant L, Gaglani M, et al
    Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Dec 20. pii: 6470720. doi: 10.1093/cid/ciab1038.
    >> Share

  131. LUO CH, Morris CP, Sachithanandham J, Amadi A, et al
    Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Recovery of Infectious Virus Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals.
    Clin Infect Dis. 2021 Dec 18. pii: 6469786. doi: 10.1093.
    >> Share

  132. LU L, Mok BW, Chen LL, Chan JM, et al
    Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients.
    Clin Infect Dis. 2021 Dec 16. pii: 6463504. doi: 10.1093/cid/ciab1041.
    >> Share

  133. SAGARA I, Zongo I, Cairns M, Yerbanga RS, et al
    The Anti-Circumsporozoite Antibody Response Of Children To Seasonal Vaccination With The Rts,S/As01e Malaria Vaccine.
    Clin Infect Dis. 2021 Dec 11. pii: 6459764. doi: 10.1093/cid/ciab1017.
    >> Share

  134. BART SM, Harizaj A, Pearson CL, Conteh T, et al
    SARS-CoV-2 Delta outbreak among fully vaccinated nursing home residents likely initiated by a fully vaccinated staff member - Connecticut, July-August 2021.
    Clin Infect Dis. 2021 Dec 10. pii: 6459157. doi: 10.1093/cid/ciab1025.
    >> Share

  135. KHAN K, Lustig G, Bernstein M, Archary D, et al
    Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV.
    Clin Infect Dis. 2021 Dec 10. pii: 6459255. doi: 10.1093/cid/ciab1008.
    >> Share

  136. ROCCO JM, Mallarino-Haeger C, Randolph AH, Ray SM, et al
    Hyperinflammatory syndromes after SARS-CoV-2 mRNA vaccination in individuals with underlying immune dysregulation.
    Clin Infect Dis. 2021 Dec 10. pii: 6459155. doi: 10.1093/cid/ciab1024.
    >> Share

  137. FERNANDEZ-GONZALEZ M, Agullo V, Padilla S, Garcia JA, et al
    Clinical performance of a standardized SARS-CoV-2 interferon-gamma release assay for simple detection of T-cell responses after infection or vaccination.
    Clin Infect Dis. 2021 Dec 10. pii: 6459152. doi: 10.1093/cid/ciab1021.
    >> Share

  138. HUANG YC, Sun HY, Sheng WH, Hsieh SM, et al
    Evolution of hepatitis B virus (HBV) serologic markers among antiretroviral-naive, young people living with HIV who had undergone neonatal HBV vaccination and initiated antiretroviral therapy.
    Clin Infect Dis. 2021 Dec 10. pii: 6459150. doi: 10.1093/cid/ciab1020.
    >> Share

  139. BUTT AA, Yan P, Shaikh OS, Mayr FB, et al
    Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons with Breakthrough SARS-CoV-2 Infection in a High-risk National Population.
    Clin Infect Dis. 2021 Dec 10. pii: 6459161. doi: 10.1093/cid/ciab1023.
    >> Share

  140. TANG L, Cherry S, Tuomanen EI, Roubidoux EK, et al
    Host predictors of broadly cross-reactive antibodies against SARS-CoV-2 variants of concern differ between infection and vaccination.
    Clin Infect Dis. 2021 Dec 10. pii: 6458694. doi: 10.1093.
    >> Share

  141. LEWIS NM, Chung JR, Uyeki TM, Grohskopf L, et al
    Interpretation of Relative Efficacy and Effectiveness for Influenza Vaccines.
    Clin Infect Dis. 2021 Dec 7. pii: 6455504. doi: 10.1093/cid/ciab1016.
    >> Share

  142. HAN A, Czajkowski L, Rosas LA, Cervantes-Medina A, et al
    Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model.
    Clin Infect Dis. 2021;73:e4260-e4268.
    >> Share

  143. WANG W, Alvarado-Facundo E, Vassell R, Collins L, et al
    Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin.
    Clin Infect Dis. 2021;73:e4312-e4320.
    >> Share

  144. MCCONEGHY KW, Davidson HE, Canaday DH, Han L, et al
    Cluster-randomized Trial of Adjuvanted Versus Nonadjuvanted Trivalent Influenza Vaccine in 823 US Nursing Homes.
    Clin Infect Dis. 2021;73:e4237-e4243.
    >> Share

  145. SKOFF TH, Faulkner AE, Liang JL, Barnes M, et al
    Pertussis Infections Among Pregnant Women in the United States, 2012-2017.
    Clin Infect Dis. 2021;73:e3836-e3841.
    >> Share

  146. BOZIO CH, Blain A, Edge K, Farley MM, et al
    Clinical Characteristics and Adverse Clinical Outcomes of Invasive Haemophilus influenzae Serotype a Cases-United States, 2011-2015.
    Clin Infect Dis. 2021;73:e3670-e3676.
    >> Share

  147. USUF E, Bottomley C, Gladstone R, Bojang E, et al
    Persistent and Emerging Pneumococcal Carriage Serotypes in a Rural Gambian Community After 10 Years of Pneumococcal Conjugate Vaccine Pressure.
    Clin Infect Dis. 2021;73:e3825-e3835.
    >> Share

  148. PEPPA M, Thomas SL, Minassian C, Walker JL, et al
    Seasonal Influenza Vaccination During Pregnancy and the Risk of Major Congenital Malformations in Live-born Infants: A 2010-2016 Historical Cohort Study.
    Clin Infect Dis. 2021;73:e4296-e4304.
    >> Share

  149. REZAHOSSEINI O, Sorensen SS, Perch M, Ekenberg C, et al
    Measles, Mumps, Rubella, and Varicella Zoster Virus Serology and Infections in Solid Organ Transplant Recipients During the First Year Posttransplantation.
    Clin Infect Dis. 2021;73:e3733-e3739.
    >> Share

  150. SPINELLI MA, Peluso MJ, Lynch KL, Yun C, et al
    Differences in Post-mRNA Vaccination SARS-CoV-2 IgG Concentrations and Surrogate Virus Neutralization Test Response by HIV Status and Type of Vaccine: a Matched Case-Control Observational Study.
    Clin Infect Dis. 2021 Dec 5. pii: 6453392. doi: 10.1093/cid/ciab1009.
    >> Share

  151. PANNUS P, Neven KY, De Craeye S, Heyndrickx L, et al
    Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naive residents of nursing homes.
    Clin Infect Dis. 2021 Dec 3. pii: 6448839. doi: 10.1093.
    >> Share

    November 2021
  152. GRUNAU B, Asamoah-Boaheng M, Lavoie PM, Karim ME, et al
    A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval.
    Clin Infect Dis. 2021 Nov 30. pii: 6446287. doi: 10.1093.
    >> Share

  153. BELAY ED, Godfred Cato S, Rao AK, Abrams J, et al
    Multisystem Inflammatory Syndrome in Adults after SARS-CoV-2 infection and COVID-19 vaccination.
    Clin Infect Dis. 2021 Nov 28. pii: 6445178. doi: 10.1093.
    >> Share

  154. CHUA GT, Kwan MYW, Chui CSL, Smith RD, et al
    Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination.
    Clin Infect Dis. 2021 Nov 28. pii: 6445179. doi: 10.1093.
    >> Share

  155. DIMEGLIO C, Herin F, Da-Silva I, Porcheron M, et al
    Post-vaccination SARS-CoV-2 antibody kinetics and protection duration.
    Clin Infect Dis. 2021 Nov 27. pii: 6444809. doi: 10.1093.
    >> Share

  156. CORREA H, Soslow JH, Dendy JM, Creech CB, et al
    Acute myopericarditis post intravenous injection of COVID-19 mRNA vaccine differs from viral myocarditis.
    Clin Infect Dis. 2021 Nov 26. pii: 6443709. doi: 10.1093.
    >> Share

  157. LI C, Chen Y, Zhao Y, Christopher Lung D, et al
    Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model.
    Clin Infect Dis. 2021 Nov 25. pii: 6438764. doi: 10.1093.
    >> Share

  158. GAZIT S, Mizrahi B, Kalkstein N, Neuberger A, et al
    BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of COVID-19 Patients.
    Clin Infect Dis. 2021 Nov 24. pii: 6437962. doi: 10.1093.
    >> Share

  159. STRATHDEE SA, Abramovitz D, Harvey-Vera A, Vera CF, et al
    Correlates of Coronavirus Disease 2019 (COVID-19) Vaccine Hesitancy Among People Who Inject Drugs in the San Diego-Tijuana Border Region.
    Clin Infect Dis. 2021 Nov 22. pii: 6433374. doi: 10.1093.
    >> Share

  160. CANADAY DH, Oyebanji OA, Keresztesy D, Payne M, et al
    Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination.
    Clin Infect Dis. 2021 Nov 19. pii: 6432026. doi: 10.1093.
    >> Share

  161. MADELON N, Lauper K, Breville G, Sabater Royo I, et al
    Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study.
    Clin Infect Dis. 2021 Nov 17. pii: 6430423. doi: 10.1093.
    >> Share

  162. POLLOCK L, Bennett A, Jere KC, Mandolo J, et al
    Plasma rotavirus-specific IgA and risk of rotavirus vaccine failure in infants in Malawi.
    Clin Infect Dis. 2021 Nov 12. pii: 6426173. doi: 10.1093.
    >> Share

  163. LIEN CE, Kuo TY, Lin YJ, Lian WC, et al
    Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
    Clin Infect Dis. 2021 Nov 5. pii: 6421519. doi: 10.1093.
    >> Share

  164. PEREZ Y, Levy ER, Joshi AY, Virk A, et al
    Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination.
    Clin Infect Dis. 2021 Nov 3. pii: 6420408. doi: 10.1093.
    >> Share

  165. SHERMAN AC, Desjardins M, Cheng CA, Bausk B, et al
    SARS-CoV-2 mRNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.
    Clin Infect Dis. 2021 Nov 2. pii: 6415965. doi: 10.1093.
    >> Share

  166. BOSCH W, Cowart JB, Bhakta S, Carter RE, et al
    COVID-19 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida through August 2021.
    Clin Infect Dis. 2021 Nov 2. pii: 6415962. doi: 10.1093.
    >> Share

  167. BRAMUGY J, Mucasse H, Massora S, Vitorino P, et al
    Short and long-term outcomes of GBS invasive disease in Mozambican children: Results of a case cohort and retrospective observational study and implications for future vaccine introduction.
    Clin Infect Dis. 2021 Nov 2. pii: 6388780. doi: 10.1093.
    >> Share

  168. MALVOLTI S, Pecenka C, Mantel C, Malhame M, et al
    A financial and global demand analysis to inform decisions for funding and clinical development of GBS vaccines for pregnant women.
    Clin Infect Dis. 2021 Nov 2. pii: 6412619. doi: 10.1093.
    >> Share

  169. BROWN NE, Blain AE, Burzlaff K, Harrison LH, et al
    Racial Disparities in Invasive Haemophilus influenzae Disease-United States, 2008-2017.
    Clin Infect Dis. 2021;73:1617-1624.
    >> Share

  170. BERENSON AB, Hirth JM, Chang M
    Prevalence of Genital Human Papillomavirus by Age and Race/Ethnicity Among Males.
    Clin Infect Dis. 2021;73:1625-1633.
    >> Share

  171. MIELLET WR, van Veldhuizen J, Nicolaie MA, Mariman R, et al
    Influenza-like Illness Exacerbates Pneumococcal Carriage in Older Adults.
    Clin Infect Dis. 2021;73:e2680-e2689.
    >> Share

  172. THOMPSON RR, Kong CL, Porco TC, Kim E, et al
    Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United States.
    Clin Infect Dis. 2021;73:e3210-e3217.
    >> Share

  173. ISHIKAWA T, Okai M, Mochizuki E, Uchiyama T, et al
    Bacillus Calmette-Guerin (BCG) Infections at High Frequency in Both AR-CGD and X-CGD Patients Following BCG Vaccination.
    Clin Infect Dis. 2021;73:e2538-e2544.
    >> Share

  174. TESSIER E, Campbell H, Ribeiro S, Fry NK, et al
    Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014-2018.
    Clin Infect Dis. 2021;73:e2502-e2508.
    >> Share

  175. LEE JH, Lee YB, Cho EJ, Yu SJ, et al
    Entecavir Plus Pegylated Interferon and Sequential Hepatitis B Virus Vaccination Increases Hepatitis B Surface Antigen Seroclearance: A Randomized Controlled Proof-of-Concept Study.
    Clin Infect Dis. 2021;73:e3308-e3316.
    >> Share

    October 2021
  176. MARSHALL GS, Ghaswalla PK, Bengtson LGS, Buikema AR, et al
    Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the United States.
    Clin Infect Dis. 2021 Oct 28. pii: 6413775. doi: 10.1093.
    >> Share

  177. WILLIAMS LR, Ferguson NM, Donnelly CA, Grassly NC, et al
    Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates.
    Clin Infect Dis. 2021 Oct 26. pii: 6410688. doi: 10.1093.
    >> Share

  178. THEISS-NYLAND K, Shakya M, Colin-Jones R, Voysey M, et al
    Corrigendum to: Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.
    Clin Infect Dis. 2021 Oct 26. pii: 6410706. doi: 10.1093.
    >> Share

  179. MUHSEN K, Maimon N, Mizrahi A, Bodenneimer O, et al
    Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study.
    Clin Infect Dis. 2021 Oct 26. pii: 6410737. doi: 10.1093.
    >> Share

  180. WOLDEMESKEL BA, Garliss CC, Blankson JN
    mRNA Vaccine-Elicited SARS-CoV-2-Specific T cells Persist at 6 Months and Recognize the Delta Variant.
    Clin Infect Dis. 2021 Oct 25. pii: 6409907. doi: 10.1093.
    >> Share

  181. WALDMAN SE, Buehring T, Escobar DJ, Gohil SK, et al
    Secondary Cases of Delta-Variant COVID-19 Among Vaccinated Healthcare Workers with Breakthrough Infections is Rare.
    Clin Infect Dis. 2021 Oct 25. pii: 6409806. doi: 10.1093.
    >> Share

  182. BHIMRAJ A, Morgan RL, Shumaker AH, Lavergne V, et al
    Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-Edged Swords.
    Clin Infect Dis. 2021 Oct 20. pii: 6398590. doi: 10.1093.
    >> Share

  183. ROBILOTTI EV, Whiting K, Lucca A, Poon C, et al
    Clinical and Genomic Characterization of SARS CoV-2 infections in mRNA Vaccinated Health Care Personnel in New York City.
    Clin Infect Dis. 2021 Oct 13. pii: 6396142. doi: 10.1093.
    >> Share

  184. ISTURIZ R, Grant L, Gray S, Alexander-Parrish R, et al
    Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults.
    Clin Infect Dis. 2021;73:1216-1222.
    >> Share

  185. LADHANI SN, Campbell H, Andrews N, Parikh SR, et al
    First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, England.
    Clin Infect Dis. 2021;73:e1661-e1668.
    >> Share

  186. MARSHALL HS, Maiden MCJ
    Impact of a Meningococcal Protein-based Serogroup B Vaccine on Serogroup W Invasive Disease in Children.
    Clin Infect Dis. 2021;73:e1669-e1672.
    >> Share

  187. HUANG W, Chiu NC, Chi H, Huang FY, et al
    Inoculation Age of Bacillus Calmette-Guerin Tokyo-172 Strain and Vaccine-related Adverse Reactions in Taiwan Birth Cohort of 2012-2017.
    Clin Infect Dis. 2021;73:e1554-e1559.
    >> Share

  188. MARIN M, Fiebelkorn AP, Bi D, Coleman LA, et al
    Adverse Events Among Young Adults Following a Third Dose of Measles-Mumps-Rubella Vaccine.
    Clin Infect Dis. 2021;73:e1546-e1553.
    >> Share

  189. HURLEY D, Griffin C, Young M, Scott DA, et al
    Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.
    Clin Infect Dis. 2021;73:e1489-e1497.
    >> Share

  190. RIVERA L, Biswal S, Saez-Llorens X, Reynales H, et al
    Three years efficacy and safety of Takeda's dengue vaccine candidate (TAK-003).
    Clin Infect Dis. 2021 Oct 4. pii: 6381105. doi: 10.1093.
    >> Share

    September 2021
  191. MANTEL C, Cherian T, Ko M, Malvoti S, et al
    Stakeholder perceptions about Group B Streptococcus disease and potential for maternal vaccination in low and middle-income countries.
    Clin Infect Dis. 2021 Sep 24. pii: 6374850. doi: 10.1093.
    >> Share

  192. ZHU F, Jin P, Zhu T, Wang W, et al
    Safety and immunogenicity of a recombinant adenovirus type-5-vectored COVID-19 vaccine with a homologous prime-boost regimen in healthy participants aged 6 years and above: a randomised, double-blind, placebo-controlled, phase 2b trial.
    Clin Infect Dis. 2021 Sep 22. pii: 6374123. doi: 10.1093.
    >> Share

  193. FRALEY E, LeMaster C, Khanal S, Banerjee D, et al
    Prior infection and age impacts antibody persistence after SARS-CoV-2 mRNA vaccine.
    Clin Infect Dis. 2021 Sep 22. pii: 6373987. doi: 10.1093.
    >> Share

  194. BUENO SM, Abarca K, Gonzalez PA, Galvez NMS, et al
    Safety and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine in a Subgroup of Healthy Adults in Chile.
    Clin Infect Dis. 2021 Sep 19. pii: 6372423. doi: 10.1093.
    >> Share

  195. OHM M, Hahne SJM, van der Ende A, Sanders EAM, et al
    Vaccine impact and effectiveness of meningococcal serogroup ACWY conjugate vaccine implementation in the Netherlands: a nationwide surveillance study.
    Clin Infect Dis. 2021 Sep 15. pii: 6370762. doi: 10.1093.
    >> Share

  196. TO KK, Li X, Lung DC, Ip JD, et al
    False COVID-19 cases due to contamination by inactivated virus vaccine.
    Clin Infect Dis. 2021 Sep 9. pii: 6367446. doi: 10.1093.
    >> Share

  197. PAWASKAR M, Burgess C, Pillsbury M, Kanibir MN, et al
    Modeling Cost-Effectiveness of Universal Varicella Vaccination With Different Varicella Vaccines in the United Kingdom.
    Clin Infect Dis. 2021;73:935-936.
    >> Share

  198. FEDER KA, Patel A, Vepachedu VR, Dominguez C, et al
    Association of E484K spike protein mutation with SARS-CoV-2 infection in vaccinated persons---Maryland, January - May 2021.
    Clin Infect Dis. 2021 Sep 2. pii: 6362726. doi: 10.1093.
    >> Share

  199. MAZUR NI, Lowensteyn YN, Willemsen JE, Gill CJ, et al
    Global Respiratory Syncytial Virus-Related Infant Community Deaths.
    Clin Infect Dis. 2021;73.
    >> Share

  200. SRIKANTIAH P, Vora P, Klugman KP
    Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies.
    Clin Infect Dis. 2021;73.
    >> Share

  201. SHAW J, Hanley S, Stewart T, Salmon DA, et al
    Health Care Personnel (HCP) attitudes about COVID-19 vaccination after emergency use authorization.
    Clin Infect Dis. 2021 Sep 1. pii: 6357694. doi: 10.1093.
    >> Share

    August 2021
  202. CARAZO S, Talbot D, Boulianne N, Brisson M, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada.
    Clin Infect Dis. 2021 Aug 30. pii: 6359881. doi: 10.1093.
    >> Share

  203. KNOWLTON KU
    Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?
    Clin Infect Dis. 2021 Aug 28. pii: 6359059. doi: 10.1093.
    >> Share

  204. BALTAS I, Boshier FAT, Williams CA, Bayzid N, et al
    Post-vaccination COVID-19: A case-control study and genomic analysis of 119 breakthrough infections in partially vaccinated individuals.
    Clin Infect Dis. 2021 Aug 19. pii: 6354928. doi: 10.1093.
    >> Share

  205. YILDIRIM I, Kao CM, Tippett A, Suntarattiwong P, et al
    A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Hospitalizations in Children.
    Clin Infect Dis. 2021 Aug 19. pii: 6354891. doi: 10.1093.
    >> Share

  206. DAWOOD FS, Varner M, Tita A, Newes-Adeyi G, et al
    Incidence, Clinical Characteristics, and Risk Factors of SARS-CoV-2 Infection among Pregnant Individuals in the United States.
    Clin Infect Dis. 2021 Aug 19. pii: 6354856. doi: 10.1093.
    >> Share

  207. LI C, Chen Y, Zhao Y, Lung DC, et al
    Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model.
    Clin Infect Dis. 2021 Aug 18. pii: 6353927. doi: 10.1093.
    >> Share

  208. DIMEGLIO C, Herin F, Da-Silva I, Jougla I, et al
    Heterologous ChAdOx1-S/BNT162b2 vaccination: neutralizing antibody response to SARS-CoV-2.
    Clin Infect Dis. 2021 Aug 12. pii: 6349304. doi: 10.1093.
    >> Share

  209. NORTH CM, Barczak A, Goldstein RH, Healy BC, et al
    Determining the Incidence of Asymptomatic SARS-CoV-2 among Early Recipients of COVID-19 Vaccines: A Prospective Cohort Study of Healthcare Workers before, during and after Vaccination [DISCOVER-COVID-19].
    Clin Infect Dis. 2021 Aug 7. pii: 6345339. doi: 10.1093.
    >> Share

  210. TENFORDE MW, Patel MM, Ginde AA, Douin DJ, et al
    Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
    Clin Infect Dis. 2021 Aug 6. pii: 6343399. doi: 10.1093.
    >> Share

  211. FOURATI S, Bailly B, Le Bouter A, Guilpain L, et al
    Differential anti-S antibody titers in vaccinated residents during an outbreak of SARS-CoV-2 variant B.1.351 (beta) in an elderly nursing home.
    Clin Infect Dis. 2021 Aug 3. pii: 6338175. doi: 10.1093.
    >> Share

    July 2021
  212. GHAMANDE S, Shaver C, Murthy K, Raiyani C, et al
    Vaccine effectiveness against acute respiratory illness hospitalizations for influenza-associated pneumonia during the 2015-2016 to 2017-2018 seasons, US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    Clin Infect Dis. 2021 Jul 28. pii: 6329674. doi: 10.1093.
    >> Share

  213. BOLLAERTS K, Fletcher MA, Suaya JA, Hanquet G, et al
    Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy Trials.
    Clin Infect Dis. 2021 Jul 27. pii: 6329127. doi: 10.1093.
    >> Share

  214. CHEN LL, Lu L, Choi CY, Cai JP, et al
    Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination.
    Clin Infect Dis. 2021 Jul 26. pii: 6328361. doi: 10.1093.
    >> Share

  215. NAUCLER P, Galanis I, Petropoulos A, Granath F, et al
    Chronic disease and immunosuppression increase the risk for non-vaccine serotype pneumococcal disease - a nationwide population-based study.
    Clin Infect Dis. 2021 Jul 24. pii: 6327794. doi: 10.1093.
    >> Share

  216. CHEN X, Chen Z, Azman AS, Sun R, et al
    Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis.
    Clin Infect Dis. 2021 Jul 24. pii: 6327511. doi: 10.1093.
    >> Share

  217. WOLDEMESKEL BA, Karaba AH, Garliss CC, Beck EJ, et al
    The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living with HIV.
    Clin Infect Dis. 2021 Jul 22. pii: 6325617. doi: 10.1093.
    >> Share

  218. HALBROOK M, Gadoth A, Martin-Blais R, Gray AN, et al
    Longitudinal assessment of COVID-19 vaccine acceptance and uptake among frontline medical workers in Los Angeles, California.
    Clin Infect Dis. 2021 Jul 22. pii: 6325325. doi: 10.1093.
    >> Share

  219. BOUTRY C, Hastie A, Diez-Domingo J, Tinoco JC, et al
    The Adjuvanted Recombinant Zoster Vaccine Confers Long-term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase III Clinical Trials (ZOE-50 and ZOE-70).
    Clin Infect Dis. 2021 Jul 20. pii: 6324611. doi: 10.1093.
    >> Share

  220. ANDREJKO KL, Pry J, Myers JF, Jewell NP, et al
    Prevention of COVID-19 by mRNA-based vaccines within the general population of California.
    Clin Infect Dis. 2021 Jul 20. pii: 6324500. doi: 10.1093.
    >> Share

  221. TRAM KH, Saeed S, Bradley C, Fox B, et al
    Deliberation, Dissent, and Distrust: Understanding distinct drivers of COVID-19 vaccine hesitancy in the United States.
    Clin Infect Dis. 2021 Jul 16. pii: 6323151. doi: 10.1093.
    >> Share

  222. TOTA JE, Giuliano AR, Goldstone SE, Dubin B, et al
    Anogenital HPV Infection, Seroprevalence, and Risk Factors for HPV Seropositivity Among Sexually Active Men Enrolled in a Global HPV Vaccine Trial.
    Clin Infect Dis. 2021 Jul 15. pii: 6321740. doi: 10.1093.
    >> Share

  223. LIN DY, Gu Y, Zeng D, Janes HE, et al
    Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Jul 14. pii: 6321290. doi: 10.1093.
    >> Share

  224. IJAZ S, Derrick J, Shute J, Ireland G, et al
    Mother To Infant Transmission Of Hepatitis B Virus In The Face Of Neonatal Immunisation Is Not Necessarily Primary Vaccine Failure.
    Clin Infect Dis. 2021 Jul 12. pii: 6319332. doi: 10.1093.
    >> Share

  225. DAWOOD FS, Naleway AL, Flannery B, Levine MZ, et al
    Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial.
    Clin Infect Dis. 2021 Jul 10. pii: 6318730. doi: 10.1093.
    >> Share

  226. SKOWRONSKI DM, Setayeshgar S, Zou M, Prystajecky N, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including Alpha and Gamma variants: a test-negative design in adults 70 years and older in British Columbia, Canada.
    Clin Infect Dis. 2021 Jul 9. pii: 6318435. doi: 10.1093.
    >> Share

  227. WILLIAMS C, Al-Bargash D, Macalintal C, Stuart R, et al
    COVID-19 Outbreak Associated with a SARS-CoV-2 P.1 Lineage in a Long-Term Care Home after Implementation of a Vaccination Program - Ontario, April-May 2021.
    Clin Infect Dis. 2021 Jul 8. pii: 6317716. doi: 10.1093.
    >> Share

  228. BERENSON AB, Hirth JM, Chang M
    Prevalence of oral human papillomavirus infection: Impact of sex, race/ethnicity and vaccination status.
    Clin Infect Dis. 2021 Jul 4. pii: 6314534. doi: 10.1093.
    >> Share

  229. LUMLEY SF, Rodger G, Constantinides B, Sanderson N, et al
    An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.
    Clin Infect Dis. 2021 Jul 3. pii: 6314286. doi: 10.1093.
    >> Share

    June 2021
  230. ANDREJKO K, Whittles LK, Lewnard JA
    Health-economic value of vaccination against group A Streptococcus in the United States.
    Clin Infect Dis. 2021 Jun 30. pii: 6311854. doi: 10.1093.
    >> Share

  231. MAZZOLA A, Todesco E, Drouin S, Hazan F, et al
    Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.
    Clin Infect Dis. 2021 Jun 24. pii: 6309017. doi: 10.1093.
    >> Share

  232. MCEWEN AE, Cohen S, Bryson-Cahn C, Liu C, et al
    Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.
    Clin Infect Dis. 2021 Jun 24. pii: 6309019. doi: 10.1093.
    >> Share

  233. DIMEGLIO C, Herin F, Da-Silva I, Porcheron M, et al
    Strong SARS-CoV-2-neutralizing antibody response of previously-infected healthcare workers given one dose of mRNA vaccine.
    Clin Infect Dis. 2021 Jun 22. pii: 6307902. doi: 10.1093.
    >> Share

  234. JACOBSON KB, Pinsky BA, Montez Rath ME, Wang H, et al
    Post-vaccination SARS-CoV-2 infections and incidence of presumptive B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center.
    Clin Infect Dis. 2021 Jun 17. pii: 6303032. doi: 10.1093.
    >> Share

  235. STANKOV MV, Cossmann A, Bonifacius A, Dopfer-Jablonka A, et al
    Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.
    Clin Infect Dis. 2021 Jun 16. pii: 6301133. doi: 10.1093.
    >> Share

  236. METCALF BJ, Chochua S, Walker H, Tran T, et al
    Invasive Pneumococcal Strain Distributions and Isolate Clusters Associated With Persons Experiencing Homelessness During 2018.
    Clin Infect Dis. 2021;72:e948-e956.
    >> Share

  237. POLLETT SD, Richard SA, Fries AC, Simons MP, et al
    The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity.
    Clin Infect Dis. 2021 Jun 12. pii: 6297424. doi: 10.1093.
    >> Share

  238. CURREN EJ, Shankar MB, Fischer M, Meltzer MI, et al
    Cost effectiveness and impact of a targeted age- and incidence-based West Nile virus vaccine strategy.
    Clin Infect Dis. 2021 Jun 12. pii: 6297173. doi: 10.1093.
    >> Share

  239. VANKER A, McGeer A, O'Byrne G, Snyder ECR, et al
    Adverse Outcomes Associated with SARS-CoV-2 variant B.1.351 Infection in Vaccinated Residents of a Long Term Care Home, Ontario, Canada.
    Clin Infect Dis. 2021 Jun 6. pii: 6294072. doi: 10.1093.
    >> Share

  240. MWENDA JM, Hallowell BD, Parashar U, Shaba K, et al
    Impact of rotavirus vaccine introduction on rotavirus hospitalizations among children under 5 years of age - World Health Organization African Region, 2008-2018.
    Clin Infect Dis. 2021 Jun 5. pii: 6293961. doi: 10.1093.
    >> Share

  241. JACOBSON MA, Zakaria A, Maung Z, Hart C, et al
    Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 SARS-CoV2 Vaccine (Moderna) in a Cohort of Hospital Employees.
    Clin Infect Dis. 2021 Jun 4. pii: 6291929. doi: 10.1093.
    >> Share

  242. KAHN R, Holmdahl I, Reddy S, Jernigan J, et al
    Mathematical modeling to inform vaccination strategies and testing approaches for COVID-19 in nursing homes.
    Clin Infect Dis. 2021 Jun 4. pii: 6292250. doi: 10.1093.
    >> Share

  243. YEH HF
    The potential declining efficacy of the ChAdOx1 nCoV-19 vaccine(AZD1222) on inoculators with NSAIDs intake.
    Clin Infect Dis. 2021 Jun 3. pii: 6291428. doi: 10.1093.
    >> Share

  244. WYLLIE AL, Warren JL, Regev-Yochay G, Givon-Lavi N, et al
    Serotype Patterns of Pneumococcal Disease in Adults Are Correlated With Carriage Patterns in Older Children.
    Clin Infect Dis. 2021;72:e768-e775.
    >> Share

  245. AFRICANO HF, Serrano-Mayorga CC, Ramirez-Valbuena PC, Bustos IG, et al
    Major Adverse Cardiovascular Events During Invasive Pneumococcal Disease Are Serotype Dependent.
    Clin Infect Dis. 2021;72:e711-e719.
    >> Share

    May 2021
  246. MAROT S, Malet I, Leducq V, Abdi B, et al
    Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers.
    Clin Infect Dis. 2021 May 29. pii: 6288468. doi: 10.1093.
    >> Share

  247. GOWER CM, Stowe J, Andrews NJ, Dunning J, et al
    Sustained declines in age group-specific rotavirus infection and acute gastroenteritis in vaccinated and unvaccinated individuals during the five years since Rotavirus vaccine introduction in England.
    Clin Infect Dis. 2021 May 27. pii: 6287118. doi: 10.1093.
    >> Share

  248. NEWALL AT, Leong RN, Reyes JF, Curns AT, et al
    Rotavirus vaccination likely to be cost saving to society in the United States.
    Clin Infect Dis. 2021 May 26. pii: 6285405. doi: 10.1093.
    >> Share

  249. YADAV PD, Sapkal GN, Abraham P, Deshpande G, et al
    Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1.
    Clin Infect Dis. 2021 May 24. pii: 6283706. doi: 10.1093.
    >> Share

  250. KOELMAN DLH, Brouwer MC, Ter Horst L, Bijlsma MW, et al
    Pneumococcal meningitis in adults: a prospective nationwide cohort studY over a 20-year period.
    Clin Infect Dis. 2021 May 24. pii: 6283697. doi: 10.1093.
    >> Share

  251. OGATA AF, Cheng CA, Desjardins M, Senussi Y, et al
    Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients.
    Clin Infect Dis. 2021 May 20. pii: 6279075. doi: 10.1093.
    >> Share

  252. GRIJALVA CG, Feldstein LR, Talbot HK, Aboodi M, et al
    Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness among Adults in the United States, 2019-2020: A test-negative study.
    Clin Infect Dis. 2021 May 20. pii: 6279050. doi: 10.1093.
    >> Share

  253. DANINO D, Van Der Beek BA, Givon-Lavi N, Greenberg D, et al
    Unravelling the Impact of Pneumococcal Conjugate Vaccines on Ambulatory Antibiotic Drug Consumption in Young Children: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2021 May 20. pii: 6278471. doi: 10.1093.
    >> Share

  254. ROYER G, Clermont O, Condamine B, Mercier-Darty M, et al
    O-antigen targeted vaccines against E. coli may be useful in reducing morbidity, mortality and antimicrobial resistance.
    Clin Infect Dis. 2021 May 17. pii: 6277090. doi: 10.1093.
    >> Share

  255. CHODICK G, Tene L, Rotem RS, Patalon T, et al
    The effectiveness of the TWO-DOSE BNT162b2 vaccine: analysis of real-world data.
    Clin Infect Dis. 2021 May 17. pii: 6276888. doi: 10.1093.
    >> Share

  256. BAILLY B, Guilpain L, Bouiller K, Chirouze C, et al
    BNT162b2 mRNA vaccination did not prevent an outbreak of SARS COV-2 variant 501Y.V2 in an elderly nursing home but reduced transmission and disease severity.
    Clin Infect Dis. 2021 May 16. pii: 6276392. doi: 10.1093.
    >> Share

  257. CANADAY DH, Carias L, Oyebanji OA, Keresztesy D, et al
    Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents.
    Clin Infect Dis. 2021 May 16. pii: 6276391. doi: 10.1093.
    >> Share

  258. PALEFSKY JM, Lensing SY, Belzer M, Lee J, et al
    High prevalence of anal high-grade squamous intraepithelial lesions, and prevention through human papillomavirus vaccination, in young men who have sex with men living with HIV.
    Clin Infect Dis. 2021 May 15. pii: 6276233. doi: 10.1093.
    >> Share

  259. VANIJCHAROENKARN K, Lee FE, Martin L, Shih J, et al
    Immediate reactions following the first dose of the SARS-CoV2 mRNA vaccines do not preclude second dose administration.
    Clin Infect Dis. 2021 May 14. pii: 6275836. doi: 10.1093.
    >> Share

  260. SAMI S, Tenforde MW, Talbot HK, Lindsell CJ, et al
    Adults Hospitalized with COVID-19 -United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes.
    Clin Infect Dis. 2021 May 12. pii: 6270754. doi: 10.1093.
    >> Share

  261. MARKS SM, Clara A, Fiebelkorn AP, Le X, et al
    Influenza Vaccination in Health Centers during the COVID-19 Pandemic-United States, November 7-27, 2020.
    Clin Infect Dis. 2021 May 12. pii: 6274304. doi: 10.1093.
    >> Share

  262. YADAV PD, Sapkal GN, Abraham P, Ella R, et al
    Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees.
    Clin Infect Dis. 2021 May 7. pii: 6271524. doi: 10.1093.
    >> Share

  263. MALOSH RE, Petrie JG, Callear A, Truscon R, et al
    Effectiveness of Influenza Vaccines in the HIVE household cohort over 8 years: is there evidence of indirect protection?
    Clin Infect Dis. 2021 May 5. pii: 6265275. doi: 10.1093.
    >> Share

  264. ORTIZ JR, Yu SL, Driscoll AJ, Williams SR, et al
    The operational feasibility of vaccination programs targeting influenza risk groups in the WHO African and South-East Asian Regions.
    Clin Infect Dis. 2021 May 5. pii: 6265274. doi: 10.1093.
    >> Share

  265. ROSE K, Grant-Kels JM, Striano P, Neubauer D, et al
    Warp speed for COVID-19 drugs and vaccines - time to re-consider how we use the term 'children'.
    Clin Infect Dis. 2021 May 5. pii: 6265295. doi: 10.1093.
    >> Share

  266. ANDERSON EJ, Kamidani S, Orenstein W, Campbell JD, et al
    COVID-19 Vaccines Have Moved Out of Neutral, but Still Gearing Up in Children.
    Clin Infect Dis. 2021 May 5. pii: 6265296. doi: 10.1093.
    >> Share

  267. HAIDAR G, Mellors JW
    Improving the Outcomes of Immunocompromised Patients with COVID-19.
    Clin Infect Dis. 2021 May 5. pii: 6265293. doi: 10.1093.
    >> Share

  268. BENET T, Amour S, Valette M, Saadatian-Elahi M, et al
    Incidence of Asymptomatic and Symptomatic Influenza Among Healthcare Workers: A Multicenter Prospective Cohort Study.
    Clin Infect Dis. 2021;72:e311-e318.
    >> Share

  269. SALAMA M, Indenbaum V, Nuss N, Savion M, et al
    A Measles Outbreak in the Tel Aviv District, Israel, 2018-2019.
    Clin Infect Dis. 2021;72:1649-1656.
    >> Share

    April 2021
  270. BEALL RF, Kesselheim AS, Hollis A
    Pre-market development times for innovative vaccines - to what extent are the COVID-19 vaccines outliers?
    Clin Infect Dis. 2021 Apr 29. pii: 6259217. doi: 10.1093.
    >> Share

  271. LAWS RL, Biraro S, Kirungi W, Gianetti B, et al
    COVID-19 Mitigation Efforts and Testing During an In-Person Training Event - Uganda, October 12-29, 2020.
    Clin Infect Dis. 2021 Apr 29. pii: 6257593. doi: 10.1093.
    >> Share

  272. MULLER L, Andree M, Moskorz W, Drexler I, et al
    Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination.
    Clin Infect Dis. 2021 Apr 27. pii: 6255965. doi: 10.1093.
    >> Share

  273. PAPAYANNI PG, Chasiotis D, Koukoulias K, Georgakopoulou A, et al
    Vaccinated and convalescent donor-derived SARS-CoV-2-specific T cells as adoptive immunotherapy for high-risk COVID-19 patients.
    Clin Infect Dis. 2021 Apr 27. pii: 6255711. doi: 10.1093.
    >> Share

  274. SWIFT MD, Breeher LE, Tande AJ, Tommaso CP, et al
    Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel.
    Clin Infect Dis. 2021 Apr 26. pii: 6253721. doi: 10.1093.
    >> Share

  275. COHEN R, Levy C, Ouldali N, Goldrey M, et al
    Invasive Disease Potential of Pneumococcal Serotypes in Children After PCV13 Implementation.
    Clin Infect Dis. 2021;72:1453-1456.
    >> Share

  276. LILLIE PJ, O'Brien P, Lawtie M, Jessop S, et al
    First dose of BNT162b2 mRNA vaccine in a Health Care Worker cohort is associated with reduced symptomatic and asymptomatic SARS-CoV-2 infection.
    Clin Infect Dis. 2021 Apr 24. pii: 6248435. doi: 10.1093.
    >> Share

  277. RANE MS, Halloran ME
    Estimating population-level effects of the acellular pertussis vaccine using routinely collected immunization data.
    Clin Infect Dis. 2021 Apr 21. pii: 6243988. doi: 10.1093.
    >> Share

  278. DAGAN R, Ben-Shimol S, Greenberg D, Givon-Lavi N, et al
    A Prospective, Population-based Study to Determine the Incidence and Bacteriology of Bacterial Conjunctivitis in Children <2 Years of Age Following 7-Valent and 13-Valent Pneumococcal Conjugate Vaccine Sequential Implementation.
    Clin Infect Dis. 2021;72:1200-1207.
    >> Share

  279. VAN PRAET JT, Vandecasteele S, De Roo A, De Vriese AS, et al
    Humoral and cellular immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in nursing home residents.
    Clin Infect Dis. 2021 Apr 7. pii: 6213866. doi: 10.1093.
    >> Share

  280. WESTHOLTER D, Taube C
    SARS-CoV-2 outbreak in a long-term care facility after vaccination with BNT162b2.
    Clin Infect Dis. 2021 Apr 7. pii: 6213878. doi: 10.1093.
    >> Share

  281. FORRAT R, Dayan GH, DiazGranados CA, Bonaparte M, et al
    Analysis of hospitalized and severe dengue cases over the six-years of follow-up of the tetravalent dengue vaccine (CYD-TDV) efficacy trials in Asia and Latin America.
    Clin Infect Dis. 2021 Apr 4. pii: 6210060. doi: 10.1093.
    >> Share

  282. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Zigron R, et al
    Efficient maternofetal transplacental transfer of anti- SARS-CoV-2 spike antibodies after antenatal SARS-CoV-2 BNT162b2 mRNA vaccination.
    Clin Infect Dis. 2021 Apr 3. pii: 6209876. doi: 10.1093.
    >> Share

    March 2021
  283. HALSTEAD SB
    Is Dengue Vaccine Protection Possible?
    Clin Infect Dis. 2021 Mar 31. pii: 6206739. doi: 10.1093.
    >> Share

  284. KISSLER SM, Mitchell M, Grad YH
    Reduction in antibiotic prescribing attainable with a gonococcal vaccine.
    Clin Infect Dis. 2021 Mar 31. pii: 6205093. doi: 10.1093.
    >> Share

  285. DEGRAZIA D, Miller FG
    SARS-CoV-2 Infection Challenge Experiments in Nonhuman Primates: An Ethical Perspective.
    Clin Infect Dis. 2021 Mar 31. pii: 6205379. doi: 10.1093.
    >> Share

  286. BODDINGTON NL, Pearson I, Whitaker H, Mangtani P, et al
    Effectiveness of influenza vaccination in preventing hospitalisation due to influenza in children: a systematic review and meta-analysis.
    Clin Infect Dis. 2021 Mar 27. pii: 6193428. doi: 10.1093.
    >> Share

  287. ORIJE MRP, Lariviere Y, Herzog SA, Mahieu LM, et al
    Breast milk antibody levels in Tdap vaccinated women after preterm delivery.
    Clin Infect Dis. 2021 Mar 26. pii: 6188768. doi: 10.1093.
    >> Share

  288. MCELLISTREM MC, Clancy CJ, Buehrle DJ, Lucas A, et al
    Single dose of a mRNA SARS-CoV-2 vaccine is associated with lower nasopharyngeal viral load among nursing home residents with asymptomatic COVID-19.
    Clin Infect Dis. 2021 Mar 26. pii: 6188727. doi: 10.1093.
    >> Share

  289. ECKSTEIN L, Rid A, Kamuya D, Shah SK, et al
    The essential role of DSMBs in ensuring the ethics of global vaccine trials to address COVID-19.
    Clin Infect Dis. 2021 Mar 24. pii: 6184613. doi: 10.1093.
    >> Share

  290. WALL N, Godlee A, Geh D, Jones C, et al
    Latent cytomegalovirus infection and previous capsular polysaccharide vaccination predict poor vaccine responses in older adults, independent of chronic kidney disease.
    Clin Infect Dis. 2021 Mar 17. pii: 6174428. doi: 10.1093.
    >> Share

  291. CZAJA CA, Cockburn MG, Colborn K, Miller L, et al
    Adult population coverage with influenza vaccine and influenza hospitalization rates-is there a role for active outreach to immunize at-risk neighborhoods?
    Clin Infect Dis. 2021 Mar 14. pii: 6170704. doi: 10.1093.
    >> Share

  292. TANDE AJ, Pollock BD, Shah ND, Farrugia G, et al
    Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening.
    Clin Infect Dis. 2021 Mar 10. pii: 6167855. doi: 10.1093.
    >> Share

  293. LIN DY, Zeng D, Gilbert PB
    Evaluating the Long-Term Efficacy of COVID-19 Vaccines.
    Clin Infect Dis. 2021 Mar 10. pii: 6167839. doi: 10.1093.
    >> Share

  294. CAPETTI AF, Stangalini CA, Borgonovo F, Mileto D, et al
    Impressive boosting of anti-S1/S2 IgG production in COVID-19-experienced patients after the first shot of the BNT162b2 mRNA COVID-19 Vaccine.
    Clin Infect Dis. 2021 Mar 6. pii: 6159798. doi: 10.1093.
    >> Share

  295. RAPAKA RR, Hammershaimb EA, Neuzil KM
    Are some COVID vaccines better than others? Interpreting and comparing estimates of efficacy in trials of COVID-19 vaccines.
    Clin Infect Dis. 2021 Mar 6. pii: 6159795. doi: 10.1093.
    >> Share

    February 2021
  296. EYAL N, Lipsitch M
    How to test SARS-CoV-2 vaccines ethically even after one is available.
    Clin Infect Dis. 2021 Feb 26. pii: 6152007. doi: 10.1093.
    >> Share

  297. MEITES E, Stone L, Amiling R, Singh V, et al
    Significant Declines in Juvenile Onset Recurrent Respiratory Papillomatosis following HPV Vaccine Introduction in the United States.
    Clin Infect Dis. 2021 Feb 23. pii: 6148742. doi: 10.1093.
    >> Share

  298. BOIKOS C, Fischer L, O'Brien D, Vasey J, et al
    Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-Derived Quadrivalent Inactivated Influenza Vaccines and High-Dose Trivalent Influenza Vaccine in Preventing Influenza-Related Medical Encounters in US Adults >/=65
    Clin Infect Dis. 2021 Feb 19. pii: 6144977. doi: 10.1093.
    >> Share

  299. MCMILLAN M, Wang B, Koehler AP, Sullivan TR, et al
    Impact of meningococcal B vaccine on invasive meningococcal disease in adolescents.
    Clin Infect Dis. 2021 Feb 15. pii: 6136296. doi: 10.1093/cid/ciaa1636.
    >> Share

  300. SUN Y, Kim E, Kong CL, Arnold BF, et al
    Effectiveness of the recombinant zoster vaccine in adults aged 50 and older in the United States: a claims-based cohort study.
    Clin Infect Dis. 2021 Feb 13. pii: 6134288. doi: 10.1093.
    >> Share

  301. FELDMAN AG, O'Leary ST, Isakov LD
    The Risk of Resurgence in Vaccine Preventable Infections Due to COVID-Related Gaps in Immunization.
    Clin Infect Dis. 2021 Feb 13. pii: 6134309. doi: 10.1093.
    >> Share

  302. IZURIETA HS, Wu X, Forshee R, Lu Y, et al
    Recombinant Zoster Vaccine (Shingrix) real-world effectiveness in the first two years post-licensure.
    Clin Infect Dis. 2021 Feb 13. pii: 6134290. doi: 10.1093.
    >> Share

  303. HARPAZ R
    The Effectiveness of Recombinant Zoster Vaccine: Observations in the Wild.
    Clin Infect Dis. 2021 Feb 13. pii: 6134291. doi: 10.1093.
    >> Share


  304. Corrigendum to: Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies.
    Clin Infect Dis. 2021 Feb 12. pii: 6134004. doi: 10.1093/cid/ciaa1767.
    >> Share

  305. MOMPLAISIR F, Haynes N, Nkwihoreze H, Nelson M, et al
    Understanding Drivers of COVID-19 Vaccine Hesitancy Among Blacks.
    Clin Infect Dis. 2021 Feb 9. pii: 6131729. doi: 10.1093.
    >> Share

  306. WOLTER N, Cohen C, Tempia S, Walaza S, et al
    Epidemiology of pertussis in individuals of all ages hospitalised with respiratory illness in South Africa, January 2013 - December 2018.
    Clin Infect Dis. 2021 Feb 2. pii: 6126768. doi: 10.1093.
    >> Share

  307. CANADAY DH, Gravenstein S
    On Setting Expectations for a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
    Clin Infect Dis. 2021;72:513-514.
    >> Share

  308. KAO CM, Orenstein WA, Anderson EJ
    The Importance of Advancing Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Children.
    Clin Infect Dis. 2021;72:515-518.
    >> Share

  309. ANDERSEN MA, Niemann CU, Rostgaard K, Dalby T, et al
    Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study.
    Clin Infect Dis. 2021;72:463-471.
    >> Share

    January 2021
  310. LI C, Chen YX, Liu FF, Lee AC, et al
    Absence of vaccine-enhanced disease with unexpected positive protection against SARS-CoV-2 by inactivated vaccine given within three days of virus challenge in Syrian hamster model.
    Clin Infect Dis. 2021 Jan 30. pii: 6124512. doi: 10.1093.
    >> Share

  311. PEPPA D, Reeves M
    Poor responses to Pneumococcal vaccination in CKD patients - do we need to talk about cytomegalovirus again?
    Clin Infect Dis. 2021 Jan 30. pii: 6124513. doi: 10.1093.
    >> Share

  312. GOTTLIEB RL, Spak CW
    The Olympiad of SARS-CoV-2 vaccinology: Fundamentals to Complement Technical Frontiers.
    Clin Infect Dis. 2021 Jan 30. pii: 6124447. doi: 10.1093.
    >> Share

  313. MOGHADAS SM, Vilches TN, Zhang K, Wells CR, et al
    The impact of vaccination on COVID-19 outbreaks in the United States.
    Clin Infect Dis. 2021 Jan 30. pii: 6124429. doi: 10.1093.
    >> Share

  314. PAWASKAR M, Burgess C, Pillsbury M, Kanibir MN, et al
    Modeling Cost Efectiveness of Universal Varicella Vaccination with Different Varicella Vaccines in the UK.
    Clin Infect Dis. 2021 Jan 28. pii: 6122568. doi: 10.1093.
    >> Share

  315. DAGAN R, van der Beek BA, Ben-Shimol S, Pilishvili T, et al
    Effectiveness of the seven- and thirteen valent pneumococcal conjugate vaccines against vaccine-serotype otitis media.
    Clin Infect Dis. 2021 Jan 28. pii: 6122570. doi: 10.1093.
    >> Share

  316. BIENIASZ P
    The case against delaying SARS-CoV-2 mRNA vaccine boosting doses.
    Clin Infect Dis. 2021 Jan 27. pii: 6121510. doi: 10.1093.
    >> Share

  317. CAMPBELL AP, Ogokeh C, Weinberg GA, Boom JA, et al
    Effect of Vaccination on Preventing Influenza-Associated Hospitalizations Among Children During a Severe Season Associated with B/Victoria Viruses, 2019-2020.
    Clin Infect Dis. 2021 Jan 27. pii: 6121316. doi: 10.1093.
    >> Share

  318. PLOTKIN SA, Halsey N
    Accelerate COVID-19 Vaccine Rollout by Delaying the Second Dose of mRNA Vaccines.
    Clin Infect Dis. 2021 Jan 27. pii: 6121304. doi: 10.1093.
    >> Share

  319. LONGLEY AT, Date K, Luby SP, Bhatnagar P, et al
    Evaluation of Vaccine Safety After the First Public Sector Introduction of Typhoid Conjugate Vaccine-Navi Mumbai, India, 2018.
    Clin Infect Dis. 2021 Jan 27. pii: 6121264. doi: 10.1093.
    >> Share

  320. MEISSNER HC, Plotkin SA
    The Facts About Vaccine Safety.
    Clin Infect Dis. 2021;72:309-310.
    >> Share

  321. MARTINS D, McCormack D, Tadrous M, Gomes T, et al
    Impact of a Publicly Funded Herpes Zoster Immunization Program on the Burden of Disease in Ontario, Canada: A Population-based Study.
    Clin Infect Dis. 2021;72:279-284.
    >> Share

  322. VERHAGEN LM, Rivera-Olivero IA, Clerc M, Chu MLJN, et al
    Nasopharyngeal Microbiota Profiles in Rural Venezuelan Children Are Associated With Respiratory and Gastrointestinal Infections.
    Clin Infect Dis. 2021;72:212-221.
    >> Share

  323. VEKEMANS J, Hasso-Agopsowicz M, Kang G, Hausdorff WP, et al
    Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: a WHO Action Framework.
    Clin Infect Dis. 2021 Jan 25. pii: 6119610. doi: 10.1093.
    >> Share

  324. SHAW J, Stewart T, Anderson KB, Hanley S, et al
    Assessment of U.S. health care personnel (HCP) attitudes towards COVID-19 vaccination in a large university health care system.
    Clin Infect Dis. 2021 Jan 25. pii: 6118651. doi: 10.1093.
    >> Share

  325. FERDINANDS JM, Gaglani M, Martin ET, Monto AS, et al
    Waning vaccine effectiveness against influenza-associated hospitalizations among adults, 2015-2016 to 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.
    Clin Infect Dis. 2021 Jan 19. pii: 6104243. doi: 10.1093.
    >> Share

  326. LIPWORTH S, Vihta KD, Chau KK, Kavanagh J, et al
    Ten years of population-level genomic Escherichia coli and Klebsiella pneumoniae serotype surveillance informs vaccine development for invasive infections.
    Clin Infect Dis. 2021 Jan 7. pii: 6067638. doi: 10.1093.
    >> Share

  327. GRAVENSTEIN S, McConeghy KW, Saade E, Davidson HE, et al
    Adjuvanted influenza vaccine and influenza outbreaks in U.S. nursing homes: Results from a pragmatic cluster-randomized clinical trial.
    Clin Infect Dis. 2021 Jan 5. pii: 6064531. doi: 10.1093/cid/ciaa1916.
    >> Share

  328. BOIKOS C, Fischer L, O'Brien D, Vasey J, et al
    Relative Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-Derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-Related Medical Encounters During the 2018-2019 Influenza Season in the United
    Clin Infect Dis. 2021 Jan 5. pii: 6064642. doi: 10.1093/cid/ciaa1944.
    >> Share

  329. TRIANT VA, Gandhi RT
    When Epidemics Collide: Why People with HIV May Have Worse COVID-19 Outcomes and Implications for Vaccination.
    Clin Infect Dis. 2021 Jan 4. pii: 6062462. doi: 10.1093/cid/ciaa1946.
    >> Share

  330. HUGHES K, Middleton DB, Nowalk MP, Balasubramani GK, et al
    Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults.
    Clin Infect Dis. 2021 Jan 3. pii: 6060064. doi: 10.1093/cid/ciaa1927.
    >> Share

    December 2020
  331. BOEY L, Curinckx A, Roelants M, Derdelinckx I, et al
    Immunogenicity And Safety Of The Nine-Valent Human Papillomavirus Vaccine In Solid Organ Transplant Recipients And Hiv-Infected Adults.
    Clin Infect Dis. 2020 Dec 29. pii: 6054974. doi: 10.1093/cid/ciaa1897.
    >> Share

  332. TENFORDE MW, Kondor RJG, Chung JR, Zimmerman RK, et al
    Effect of antigenic drift on influenza vaccine effectiveness in the United States - 2019-2020.
    Clin Infect Dis. 2020 Dec 25. pii: 6048924. doi: 10.1093/cid/ciaa1884.
    >> Share

  333. CHUNG H, Buchan SA, Campigotto A, Campitelli MA, et al
    Influenza vaccine effectiveness against all-cause mortality following laboratory-confirmed influenza in older adults, 2010-2011 to 2015-2016 seasons in Ontario, Canada.
    Clin Infect Dis. 2020 Dec 23. pii: 6044622. doi: 10.1093/cid/ciaa1862.
    >> Share

  334. LEWNARD JA, Givon-Lavi N, Dagan R
    Effectiveness of pneumococcal conjugate vaccines against community-acquired alveolar pneumonia attributable to vaccine-serotype Streptococcus pneumoniae among children.
    Clin Infect Dis. 2020 Dec 21. pii: 6042567. doi: 10.1093/cid/ciaa1860.
    >> Share

  335. LIN DY, Zeng D, Mehrotra DV, Corey L, et al
    Evaluating the Efficacy of COVID-19 Vaccines.
    Clin Infect Dis. 2020 Dec 19. pii: 6042236. doi: 10.1093/cid/ciaa1863.
    >> Share

  336. LADHANI SN, Borrow R, Ramsay ME
    Killing 2 Cocci With 1 Vaccine: Unleashing the Full Potential of an Adolescent Meningococcal B Immunization Program.
    Clin Infect Dis. 2020 Dec 19. pii: 6042098. doi: 10.1093/cid/ciaa1644.
    >> Share

  337. COHEN JI, Burbelo PD
    Reinfection with SARS-CoV-2: Implications for Vaccines.
    Clin Infect Dis. 2020 Dec 18. pii: 6041697. doi: 10.1093/cid/ciaa1866.
    >> Share

  338. KLUGMAN KP, Rodgers GL
    Impact of pneumococcal conjugate vaccine on vaccine serotype specific pneumonia.
    Clin Infect Dis. 2020 Dec 18. pii: 6041689. doi: 10.1093/cid/ciaa1867.
    >> Share

  339. CARTER AS, Luby SP, Garrett DO
    Introducing Typhoid Conjugate Vaccine in South Asia: Lessons From the Surveillance for Enteric Fever in Asia Project.
    Clin Infect Dis. 2020;71.
    >> Share

    November 2020
  340. KOELMAN DLH, van Kassel MN, Bijlsma MW, Brouwer MC, et al
    Changing Epidemiology of Bacterial Meningitis Since Introduction of Conjugate Vaccines: Three Decades of National Meningitis Surveillance in The Netherlands.
    Clin Infect Dis. 2020 Nov 28. pii: 6008501. doi: 10.1093/cid/ciaa1774.
    >> Share

  341. HOES J, Woestenberg PJ, Bogaards JA, King AJ, et al
    Population impact of girls-only HPV16/18 vaccination in the Netherlands: cross-protective and second-order herd effects.
    Clin Infect Dis. 2020 Nov 28. pii: 6010041. doi: 10.1093/cid/ciaa1770.
    >> Share

  342. MCMILLAN M, Chandrakumar A, Wang HLR, Clarke M, et al
    Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: A systematic review and meta-analysis.
    Clin Infect Dis. 2020 Nov 19. pii: 5992465. doi: 10.1093/cid/ciaa1733.
    >> Share

  343. IZURIETA HS, Lu M, Kelman J, Lu Y, et al
    Comparative effectiveness of influenza vaccines among U.S. Medicare beneficiaries ages 65 years and older during the 2019-20 season.
    Clin Infect Dis. 2020 Nov 19. pii: 5992287. doi: 10.1093/cid/ciaa1727.
    >> Share

  344. SULLIVAN SG
    The Need for Robust Epidemiological Evidence During a Pandemic.
    Clin Infect Dis. 2020;71:2289-2290.
    >> Share

  345. DAGAN R, Ben-Shimol S, Benisty R, Regev-Yochay G, et al
    A Nationwide Outbreak of Invasive Pneumococcal Disease in Israel Caused by Streptococcus Pneumoniae Serotype 2.
    Clin Infect Dis. 2020 Nov 17. pii: 5983781. doi: 10.1093/cid/ciaa1720.
    >> Share

  346. TEH BW, Leung VKY, Mordant FL, Sullivan SG, et al
    A randomised trial of two 2-dose influenza vaccination strategies for patients following autologous haematopoietic stem cell transplantation.
    Clin Infect Dis. 2020 Nov 11. pii: 5974227. doi: 10.1093/cid/ciaa1711.
    >> Share

  347. AKPO EIH, Cristeau O, Hunjan M, Casabona G, et al
    Epidemiological impact and cost-effectiveness of varicella vaccination strategies in the United Kingdom (UK).
    Clin Infect Dis. 2020 Nov 11. pii: 5973941. doi: 10.1093/cid/ciaa1708.
    >> Share

  348. NIANG MN, Sugimoto JD, Diallo A, Diarra B, et al
    Estimates of inactivated influenza vaccine effectiveness among children in Senegal: results from two consecutive cluster-randomized controlled trials in 2010 and 2011.
    Clin Infect Dis. 2020 Nov 9. pii: 5963906. doi: 10.1093/cid/ciaa1689.
    >> Share

  349. CHE Y, Liu X, Pu Y, Zhou M, et al
    Randomized, double-blinded and placebo-controlled phase II trial of an inactivated SARS-CoV-2 vaccine in healthy adults.
    Clin Infect Dis. 2020 Nov 9. pii: 5962856. doi: 10.1093/cid/ciaa1703.
    >> Share

  350. PELTON SI, Lapidot R
    Inferring public health and vaccine policies from epidemiology and whole genome sequencing of invasive pneumococcal isolates from a surveillance network.
    Clin Infect Dis. 2020 Nov 5. pii: 5957066. doi: 10.1093/cid/ciaa1688.
    >> Share

  351. SHINDE V, Cai R, Plested J, Cho I, et al
    Induction of Cross-reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-cell Responses by a Recombinant Matrix-M-Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine.
    Clin Infect Dis. 2020 Nov 4. pii: 5955953. doi: 10.1093/cid/ciaa1673.
    >> Share

    October 2020
  352. ESAULENKO EV, Yakovlev AA, Volkov GA, Sukhoruk AA, et al
    Efficacy and Safety of a 3-Antigen (Pre-S1/Pre-S2/S) Hepatitis B Vaccine: Results of a Phase 3 randomized clinical trial in the Russian Federation.
    Clin Infect Dis. 2020 Oct 29. pii: 5942941. doi: 10.1093/cid/ciaa1649.
    >> Share

  353. UJIIE M
    Trends in the incidence of reported adverse events after changing the Bacillus Calmette-Guerin vaccination age in Japan.
    Clin Infect Dis. 2020 Oct 28. pii: 5942531. doi: 10.1093/cid/ciaa1640.
    >> Share

  354. BAANDRUP L, Dehlendorff C, Kjaer SK
    One-Dose Human Papillomavirus Vaccination and the Risk of Genital Warts: A Danish Nationwide Population-based Study.
    Clin Infect Dis. 2020 Oct 13. pii: 5922377. doi: 10.1093/cid/ciaa1067.
    >> Share

  355. PAVLINAC PB, Platts-Mills JA, Tickell KD, Liu J, et al
    The clinical presentation of culture-positive and culture-negative, qPCR-attributable shigellosis in the Global Enteric Multicenter Study and derivation of a Shigella severity score: implications for pediatric Shigella vaccine trials.
    Clin Infect Dis. 2020 Oct 12. pii: 5921054. doi: 10.1093/cid/ciaa1545.
    >> Share

    September 2020
  356. XIE H, Xiang R, Wan HJ, Plant EP, et al
    Reduced Influenza B-specific Post-Vaccination Antibody Cross-reactivity in the B/Victoria Lineage Predominant 2019/20 Season.
    Clin Infect Dis. 2020 Sep 29. pii: 5912827. doi: 10.1093/cid/ciaa1481.
    >> Share

  357. BARDENHEIER BH, Baier RR, Silva JB, Gravenstein S, et al
    Persistence of Racial Inequities in Receipt of Influenza Vaccination among Nursing Home Residents in the United States.
    Clin Infect Dis. 2020 Sep 29. pii: 5912795. doi: 10.1093/cid/ciaa1484.
    >> Share

  358. DE MIGUEL S, Domenech M, Gonzalez-Camacho F, Sempere J, et al
    Nationwide trends of invasive pneumococcal disease in Spain (2009-2019) in children and adults during the pneumococcal conjugate vaccine era.
    Clin Infect Dis. 2020 Sep 29. pii: 5912816. doi: 10.1093/cid/ciaa1483.
    >> Share

  359. FIRNHABER C, Swarts A, Jezile V, Mulongo M, et al
    HPV Vaccination Prior to Loop Electroexcision Procedure does not Prevent Recurrent Cervical High Grade Squamous Intraepithelial Lesions in Women Living with HIV: a Randomized, Double-blind, Placebo-controlled Trial.
    Clin Infect Dis. 2020 Sep 25. pii: 5911567. doi: 10.1093/cid/ciaa1456.
    >> Share

  360. FELDSTEIN LR, Self WH, Ferdinands JM, Randolph AG, et al
    Incorporating real-time influenza detection into the test-negative design for estimating influenza vaccine effectiveness: The real-time test-negative design (rtTND).
    Clin Infect Dis. 2020 Sep 25. pii: 5911459. doi: 10.1093/cid/ciaa1453.
    >> Share

  361. PLUMB ID, Gounder PP, Nolen LD, Massay SC, et al
    Vaccination Status of Alaska Native Persons With Hepatitis A Virus Infection-Alaska, 1996-2018.
    Clin Infect Dis. 2020 Sep 24. pii: 5910738. doi: 10.1093/cid/ciaa1102.
    >> Share

  362. ANDERSEN A, Fisker AB, Nielsen S, Rodrigues A, et al
    National immunisation campaigns with oral polio vaccine may reduce all-cause mortality: An analysis of 13 years of demographic surveillance data from an urban African area.
    Clin Infect Dis. 2020 Sep 19. pii: 5909021. doi: 10.1093/cid/ciaa1351.
    >> Share

  363. ANDERSON EJ, Campbell JD, Creech CB, Frenck R, et al
    Warp Speed for COVID-19 Vaccines: Why are Children Stuck in Neutral?
    Clin Infect Dis. 2020 Sep 18. pii: 5908283. doi: 10.1093/cid/ciaa1425.
    >> Share

  364. LYKE KE, Singer A, Berry AA, Reyes S, et al
    Multidose Priming and Delayed Boosting Improve PfSPZ Vaccine Efficacy against Heterologous P. falciparum Controlled Human Malaria Infection.
    Clin Infect Dis. 2020 Sep 12. pii: 5904973. doi: 10.1093/cid/ciaa1294.
    >> Share

    August 2020
  365. KIRWAN PD, Amin-Chowdhury Z, Croxford SE, Sheppard C, et al
    Invasive Pneumococcal Disease in People With Human Immunodeficiency Virus in England, 1999-2017.
    Clin Infect Dis. 2020 Aug 13. pii: 5892189. doi: 10.1093.
    >> Share

  366. GIBNEY KB, MacLachlan J, Coutts R, Higgins N, et al
    Incidence of invasive pneumococcal disease higher among people notified with markers of hepatitis C virus infection: Population-based surveillance in Victoria, Australia 2001-2017.
    Clin Infect Dis. 2020 Aug 4. pii: 5880584. doi: 10.1093/cid/ciaa1110.
    >> Share

    July 2020
  367. DE GRAAF H, Ibrahim M, Hill AR, Gbesemete D, et al
    Controlled Human Infection With Bordetella pertussis Induces Asymptomatic, Immunizing Colonization.
    Clin Infect Dis. 2020;71:403-411.
    >> Share

  368. HUANG H, Xu C, Liu L, Chen L, et al
    Increased protection of earlier use of immunoprophylaxis in preventing perinatal transmission of hepatitis B virus.
    Clin Infect Dis. 2020 Jul 8. pii: 5868509. doi: 10.1093.
    >> Share

    June 2020
  369. BEN-SHIMOL S, Dagan R, Givon-Lavi N, Avital D, et al
    Use of Chest Radiography Examination as a Probe for Pneumococcal Conjugate Vaccine Impact on Lower Respiratory Tract Infections in Young Children.
    Clin Infect Dis. 2020;71:177-187.
    >> Share

  370. KITT E, Burt S, Price SM, Satchell L, et al
    Implementation of a Mandatory Influenza Vaccine Policy: A 10-Year Experience.
    Clin Infect Dis. 2020 Jun 17. pii: 5858929. doi: 10.1093.
    >> Share

  371. KANSAGRA K, Parmar D, Mendiratta SK, Patel J, et al
    A Phase 3, Randomised, Open-Label, Non-inferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG).
    Clin Infect Dis. 2020 Jun 17. pii: 5858415. doi: 10.1093.
    >> Share

    May 2020
  372. HEININGER U
    Diphtheria, Tetanus, and Pertussis: Unequal Vaccine Siblings With Distinct Characteristics.
    Clin Infect Dis. 2020 May 23. pii: 5911475. doi: 10.1093.
    >> Share

  373. MAIER HE, Nachbagauer R, Kuan G, Ng S, et al
    Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults.
    Clin Infect Dis. 2020;70:2290-2297.
    >> Share

  374. MATRAJT L, Halloran ME, Antia R
    Reply to Lindsey, Hoschler, and de Silva.
    Clin Infect Dis. 2020;70:2236-2237.
    >> Share

    April 2020
  375. NAYAGAM S, Chan P, Zhao K, Sicuri E, et al
    Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.
    Clin Infect Dis. 2020 Apr 7. pii: 5817057. doi: 10.1093.
    >> Share

    March 2020
  376. YIN S, Barker L, Ly KN, Kilmer G, et al
    Susceptibility to Hepatitis A Virus Infection in the United States, 2007-2016.
    Clin Infect Dis. 2020 Mar 20. pii: 5810334. doi: 10.1093.
    >> Share

  377. GIBNEY KB, Attwood LO, Nicholson S, Tran T, et al
    Emergence of Attenuated Measles Illness Among IgG-positive/IgM-negative Measles Cases: Victoria, Australia, 2008-2017.
    Clin Infect Dis. 2020;70:1060-1067.
    >> Share

    February 2020
  378. MONTO AS, Fukuda K
    Lessons From Influenza Pandemics of the Last 100 Years.
    Clin Infect Dis. 2020;70:951-957.
    >> Share

  379. VINK P
    Reply to Cheng et al and Nellore et al.
    Clin Infect Dis. 2020;70:720-721.
    >> Share

  380. NELLORE A, Mannon RB, Limaye AP
    Letter to the Editor.
    Clin Infect Dis. 2020;70:719.
    >> Share

    November 2019
  381. MCKAY SL, Guo A, Pergam SA, Dooling K, et al
    Herpes zoster risk in immunocompromised adults in the United States: A systematic review.
    Clin Infect Dis. 2019 Nov 2. pii: 5611148. doi: 10.1093/cid/ciz1090.
    >> Share

    October 2019
  382. GARCIA GARRIDO HM, Mak AMR, Wit FWNM, Wong GWM, et al
    Incidence and Risk Factors for Invasive Pneumococcal Disease and Community-acquired Pneumonia in Human Immunodeficiency Virus-Infected Individuals in a High-income Setting.
    Clin Infect Dis. 2019 Oct 21. pii: 5601907. doi: 10.1093.
    >> Share

    September 2019
  383. TSOLENYANU E, Bancroft RE, Sesay AK, Senghore M, et al
    Etiology of Pediatric Bacterial Meningitis Pre- and Post-PCV13 Introduction Among Children Under 5 Years Old in Lome, Togo.
    Clin Infect Dis. 2019;69.
    >> Share

    August 2019
  384. KUSHNER T, Chen Z, Tressler S, Kaufman H, et al
    Trends in Hepatitis B Infection and Immunity among Women of Childbearing Age in the United States.
    Clin Infect Dis. 2019 Aug 26. pii: 5554743. doi: 10.1093.
    >> Share

  385. PEAK CM, Stous SS, Healy JM, Hofmeister MG, et al
    Homelessness and Hepatitis A - San Diego County, 2016-2018.
    Clin Infect Dis. 2019 Aug 15. pii: 5550168. doi: 10.1093.
    >> Share

    June 2019
  386. DANANCHE C, Paranhos-Baccala G, Messaoudi M, Sylla M, et al
    Serotypes of Streptococcus pneumoniae in Children Aged <5 Years Hospitalized With or Without Pneumonia in Developing and Emerging Countries: A Descriptive, Multicenter Study.
    Clin Infect Dis. 2019 Jun 25. pii: 5522937. doi: 10.1093.
    >> Share

  387. KING H, Xing J, Dean HD, Holtzman D, et al
    Trends in prevalence of protective levels of hepatitis B surface antibody among adults aged 18-49 years with risk factors for hepatitis B virus infection-United States, 2003-2014.
    Clin Infect Dis. 2019 Jun 20. pii: 5522094. doi: 10.1093.
    >> Share

    May 2019
  388. PIERROTTI LC, Duarte-Neto AN, Song ATW, Ventura CG, et al
    Fatal Yellow Fever in a kidney transplant patient.
    Clin Infect Dis. 2019 May 11. pii: 5488071. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016